Health Articles

 

Univ

Univ.Prof.Dr.E.Minar Univ. Klinik Innere Medizin II Abteilung Angiologie Allgemeines Krankenhaus Wien Währinger Gürtel 18-20 Wien, im Jänner 2013 LISTE DER WISSENSCHAFTLICHEN
ARBEITENORIGINALARBEITEN
1. Minar E., Ehringer H., Hirschl M., Ingerle H., Konecny U., Marosi L., Endler T., Gabl F., Deutsch E.: TRANSAMINASENANSTIEG: EINE WEITGEHEND UNBEKANNTE NEBEN-WIRKUNG DER HEPARINTHERAPIE. Dtsch med Wschr 1980;105: 1713-1717 2. Kronik G., Minar E., Hutterer B., Mösslacher H., Schmoliner R.: MÖGLICHKEITEN UND GRENZEN DER SCHNITTBILDECHOKARDIO-GRAPHIE BEI DER DIAGNOSE DER BAKTERIELLEN ENDOKARDITIS. Klin Wschr 1982; 60: 171-179 3. Minar E., Ehringer H., Marosi L., Hirschl M., Konecny U., Pollak Ch., Czembirek AKUTE VENENTHROMBOSE: LOKALISATION, AUSDEHNUNG UND ÄTIOLOGIE MIT BESONDERER BERÜCKSICHTIGUNG DER PARANEO-PLASIE. Dtsch med Wschr 1982; 35: 1303-1309 4. Marosi L., Wittich G., Tscholakoff D., Pötzi R., Lochs H., Meryn S., Pollak Ch., Minar E.: MIRIZZI-SYNDROM. Dtsch med Wschr 1982; 107: 1195-1197 5. Minar E., Lochs H., Dragosics B., Pötzi R., Egger T.P., Marosi L.,Czembirek H.: SONDERFORM EINES HEPATOZELLULÄREN KARZINOMS MIT GÜNSTIGEM VERLAUF. Z Gastroenterologie 1982; 20: 384-392 6. Minar E., Zazgornik J., Schmidt P., Balcke P., Kopsa H., Kretschmer G., Marosi L., Czembirek H.: ZWEIMALIGE SPONTANE NIERENRUPTUR BEI EINEM DIALYSE-PATIENTEN. Schweiz med Wschr 1982; 112: 1934-1938 7. Pötzi R., Minar E., Pesendorfer F.X., Ferenci P., Meryn S.: NOTFALLENDOSKOPIE BEI PATIENTEN MIT CHRONISCHEM ALKOHOL-ABUSUS. Z Gastroenterologie 1982; 20: 722–727 8. Minar E., Marosi L., Kronik G., Magometschnigg D., Dudczak R., Schmidt P., EKG- UND KREISLAUFVERHALTEN UNTER KÖRPERLICHER BELASTUNG BEI PATIENTEN NACH NIERENTRANSPLANTATION. Nieren- und Hochdruckkrankheiten 1983; 12: 93-98 9. Minar E., Pötzi R., Dragosics B., Hirschl M., Lochs H., Marosi L.: NOTFALLENDOSKOPIE BEI PATIENTEN MIT LEBERZIRRHOSE. Leber Magen Darm 1983; 13: 21-26 10. Schratter M., Tscholakoff D., Czembirek H., Minar E., Marosi L.: SONOGRAPHISCHE PROBLEME BEI DER BEURTEILUNG VON ANEU-RYSMEN DER AORTA ABDOMINALIS. Rö Fo 1983; 139: 304-309 11. Lochs H., Kappl Ch., Minar E., Egger-Schödl M.: FETT IN DER PARENTERALEN ERNÄHRUNG MANGELERNÄHRTER PATIENTEN. Infusionstherapie 1983; 10: 128-131 12. Minar E., Zazgornik J., Tscholakoff D., Marosi L., Piza F.: SELTENE URSACHE EINER URETEROBSTRUKTION NACH NIERENTRANS-PLANTATION. Urologe (A) 1983; 22: 213-214 13. Marosi L., Ehringer H., Minar E., Pollak Ch., Salomonowitz E., Schmidt P., MEDIASKLEROSE BEI DIALYSEPATIENTEN UND NIERENTRANSPLAN-TIERTEN PATIENTEN. VASA 1983; 12: 103-108 14. Minar E., Jäger U., Schmidt P., Zazgornik J., Balcke P., Marosi L.: EINFLUSS DER AKUTEN VIRUSHEPATITIS B AUF DIE ERYTHROPOESE BEI CHRONISCH HÄMODIALYSIERTEN PATIENTEN. Schweiz med Wschr 1983; 113: 1082-1085 15. Zazgornik J., Dudczak R., Fuhrmann M., Marosi L., Minar E., Balcke P.: ACUTE EFFECT OF CIMETIDINE AND PIRENZEPINE ON PLASMA PARA-THYROID HORMONE AND CALCITONIN IN HAEMODIOLYZED PATIENTS. Europ J Clin Pharmacology 1983; 25: 609-613 16. Egger T.P., Lochs H., PanzerS., Minar E., Schuh R.: KLINISCHE BEDEUTUNG BAKTERIELLER KONTAMINATION VON SONDENNAHRUNG. Infusionstherapie 1983; 10: 94-98 17. Minar E., Zazgornik J., Marosi L.: LOKALE STREPTOKINASE - THROMBOLYSE EINER CIMINO-SHUNT-THROMBOSE. Dtsch med Wschr 1983; 108: 1884-1885 18. Minar E., Ehringer H., Marosi L., Pollak Ch., Czembirek H.: 7-JÄHRIGE VERLAUFSBEOBACHTUNG EINER 41-JÄHRIGEN PATIENTIN MIT MORBUS TAKAYASU. VASA 1983; 12: 383-389 19. Minar E., Ehringer H., Marosi L., Piza F., Wagner O., Czembirek H.: KLINISCHE, FUNKTIONELLE UND MORPHOLOGISCHE SPÄTERGEBNISSE NACH VENÖSER THROMBEKTOMIE. VASA 1983; 12: 346-352 20. Minar E., Tscholakoff D., Zazgornik J., Schmidt P., Balcke P., Kopsa H., ZYSTISCHE NIERENVERÄNDERUNGEN BEI CHRONISCH HÄMODIALY-SIERTEN PATIENTEN. Acta med Austriaca 1983; 10: 155-160 21. Minar E., Schmidbauer C.P., Zazgornik J., Schmidt P., Marosi L., Tscholakoff D.: PROSTATAADENEKTOMIE BEI DIALYSEPATIENTEN. Acta med Austriaca 1983; 10: 161-164 22. Marosi L., Zazgornik J., Schmidt P., Minar E., Mach K., Syre E.: PRINGLEBOURNEVILLE-SYNDROM MIT NIERENBETEILIGUNG. Nieren- und Hochdruckkrankheiten 1983; 12: 509-512 23. Marosi L., Ferenci P., Dragosics B., Kiss F., Pollak Ch., Minar E.: ZUR PROGNOSE DER LEBERZIRRHOSE. ERGEBNISSE EINER 14-JÄHRIGEN KLINISCHEN FOLGESTUDIE. Schweiz med Wschr 1983; 113: 1586-1592 24. Minar E., Zazgornik J., Marosi L.: LOCAL LOW DOSE STREPTOKINASE THROMBOLYSIS OF A THROMBOSED ARTERIOVENOUS FISTULA. Am J Nephrol 1984; 4: 66-67 25. Minar E., Tscholakoff D., Zazgornik J., Schmidt P., Marosi L., CzembirekH.: AQUIRED CYSTIC DISEASE OF THE KIDNEYS IN CHRONIC HEMODIA-LYSED AND IN RENAL TRANSPLANT PATIENTS. Eur Urol 1984; 10: 245-248 26. Minar E., Schmidbauer C.P., Zazgornik J., Schmidt P., Tscholakoff D., Marosi L.: ADENOMECTOMY IN A PATIENT ON REGULAR DIALYSIS TREATMENT. Urol Int 1984; 39: 243-245 27. Minar E., Ehringer H., Sommer G., Marosi L., Czembirek H.: PREVENTION OF POSTVENOGRAPHIC THROMBOSIS BY HEPARIN-FLUSH: FIBRINOGEN UPTAKE MEASUREMENTS. AJR 1984; 143: 629-632 28. Siegmeth W., Minar E., Graninger W., Pirich K., Zazgornik J.: FIBRONECTIN UND ANDERE IMMUNOLOGISCHE PARAMETER BEI CHRONISCHER POLYARTHRITIS. Z Rheumatol 1984; 43: 27-29 29. Minar E., Zazgornik J., Dudczak R., Marosi L.: VERHALTEN VON PHOSPHAT UND KALZIUM IM SERUM SOWIE PARA-THORMON UND KALZITONIN IM PLASMA NACH ABSETZEN ALUMINIUM-HÄLTIGER PHOSPHATBINDER BEI DIALYSEPATIENTEN.
Nieren- und Hochdruckkrankheiten 1984; 13: 52-57 30. Minar E., Zazgornik J., Dudczak R., Marosi L.: EFFECT OF COMBINATION THERAPY WITH CIMETIDINE AND PIREN-ZEPINE ON PLASMA PARATHYROID-HORMONE AND CALCITONIN LEVELS IN HEMODIALYZED PATIENTS. Klin Wschr 1984; 62: 549-553 31. Minar E., Zazgornik J., Bayer P.M., Lanschützer H., Marosi L., Mengele K.: HÄMATOLOGISCHE VERÄNDERUNGEN BEI PATIENTEN MIT CHRONI-SCHER HÄMODIALYSE- UND HÄMOFILTRATIONSBEHANDLUNG UNTER BESONDERER BERÜCKSICHTIGUNG DER FOLSÄURE- UND VITAMIN B 12-SERUMKONZENTRATIONEN. Schweiz med Wschr 1984; 114: 48-53 32. Minar E., Ehringer H., Marosi L., Sommer G., Deutsch E.: THROMBOLYSE MIT UROKINASE BEI AKUTER PHLEBOTHROMBOSE. VASA 1984; 13: 41-46 33. Hirschl M., Ehringer H., Marosi L., Minar E., Schmidt P., Zazgornik J.: PERKUTANE QUANTITATIVE SHUNTFLUSSMESSUNG UND FLUSS-MESSUNG AN GROSSEN TRANSPORTARTERIEN BEI CHRONISCHEN DIALYSEPATIENTEN. VASA 1984; 13: 159-164 34. Zazgornik J., Graninger W., Minar E., Schmidt P., Balcke P., Haubenstock A., Kopsa H.: ELEVATED PLASMA FIBRINECTIN LEVELS IN NEPHROTIC SYNDROME. Klin Wschr 1984; 62: 531-532 35. Marosi L., Ehringer H., Minar E., Pollak Ch., Ahmadi R.A., Samec P.: CAROTIS-DIAGNOSTIK MITTELS HOCHAUFLÖSENDEM ULTRASCHALL-REAL-TIME-DUPLEX-SCAN. Angio-Archiv 1984; 6: 142-146 36. Zazgornik J., Minar E., Schmidt P., Kopsa H., Balcke P., Altrichter H.: IS SERUM 1-ANTITRYPSIN DEFICIENCY A CONTRAINDICATION FOR KIDNEY TRANSPLANTATION ? Przeglad Lekarski 1985; 42: 409-411 37. Minar E., Zazgornik J.: LOCAL HIRUDIN APPLICATION - AN AID IN PREVENTING OCCLUSION OF AN ARTERIOVENOUS FISTULA IN DIALYSIS PATIENTS ? Klin Wschr 1985; 63: 190-191 38. Zazgornik J., Kopsa H., Balcke P., Minar E., Shaheen F.: VENOUS THROMBOSIS AND CYCLOSPORIN. Lancet 1985; II: 102 (Letter to the editor) 39. Schmidt P., Takacs F., Pittner H., Minar E., Balcke P., Zazgornik J., Deutsch E.: VERGLEICHENDE PHARMAKOKINETIK DES BETA-1-REZEPTOREN-BLOCKERS CELIPROLOL NACH ORALER EINZELGABE AN NIEREN-GESUNDEN UND AN PATIENTEN MIT EINGESCHRÄNKTER NIEREN-FUNKTION. Wr Klin Wschr 1985; 97: 729-732 40. Pollak Ch., Minar E., Dragosics B., Marosi L.: PRIMÄRE BILIÄRE ZIRRHOSE UND SKLERODERMIE: LANGJÄHRIGER BENIGNER VERLAUF EINER KOMPLEXEN AUTOIMMUNERKRANKUNG. Leber Magen Darm 1985; 15: 85-89 41. Marosi L., Ehringer H., Pollak Ch., Minar E., Piza F., Wagner O.: EARLY POSTOPERATIVE CHANGES AFTER DESOBLITERATION OF THE CAROTID ARTERY. Journal des Maladies Vasculaires 1986; 11: 43-51 42. Minar E., Ahmadi R.A., Ehringer H., Marosi L., Konecny U., Czembirek H.: PERKUTANE TRANSLUMINALE ANGIOPLASTIE (PTA) BEI PERIPHERER ARTERIELLER VERSCHLUSSKRANKHEIT DER UNTEREN EXTREMITÄTEN. Wr Klin Wschr 1986; 98: 33-40 43. Minar , Ehringer H., Kovacs H., Ahmadi R.A., Konecny U., Koppensteiner R., Marosi L., Sommer G.: SENSITIVITY OF 125-J-FIBRINOGEN UPTAKE TEST FOR DIAGNOSIS OF VENOUS THROMBOSIS IN HEPARINIZED PATIENTS. Klin Wschr 1986; 64: 227-230 44. Minar E., Ahmadi R., Ehringer H.: EXCESSIVE ECTASIA OF THE FEMORAL ARTERY: AN UNKNOWN LATE SEQUEL OF PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY: CASE REPORT. VASA 1986; 15: 88-90 45. Kretschmer G., Wenzl E., Wagner O., Polterauer P., Ehringer H., Minar E., INFLUENCE OF ANTICOAGULANT TREATMENT IN PREVENTING GRAFT OCCLUSION FOLLOWING SAPHENOUS VEIN BYPASS FOR FEMOROPOPLI-TEAL OCCLUSIVE DISEASE. Br J Surg 1986; 73: 689-692 46. Zazgornik J., Scholz N., Kuska J., Minar E.: PLASMA CONCENTRATIONS OF KETANSERIN IN CHRONIC HEMODIALY-ZED PATIENTS. Int J Clin Pharmacol Ther Toxicol 1986; 24: 674-676 47. Mostbeck G., Gassner A., Sommer G., Minar E., Pichler M.: KOMPLETTE AV-BLOCKIERUNG WÄHREND EINER EINSCHWEMMKATHE-TERUNTERSUCHUNG MITTELS SWAN-GAZE-KATHETER. Z Kardiol 1986; 75: 700-703 48. Zilla P., Fasol R., Minar E., Kadletz M., Fischlein T., Deutsch M.: DER KLINISCHE EINSATZ DER ENDOTHELZELL-KULTIVIERUNG BEIM ALLOPLASTISCHEN GEFÄSSERSATZ. Angio 1986; 8: 337-341 49. Kretschmer G., Wenzl E., Piza F., Polterauer P., Ehringer H., Minar E., Schemper M.: THE INFLUENCE OF ANTICOAGULANT TREATMENT ON THE PROBABILI-TY OF FUNCTION IN FEMOROPOPLITEAL VEIN BYPASS SURGERY. Analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial. Surgery 1987; 102: 453-459 50. Minar E., Ehringer H.: INFLUENCE OF ACETYLSALICYLIC ACID (1.0g/DAY) ON PLATELET SURVIVAL TIME, ß-THROMBOGLOBULIN AND PLATELET FACTOR 4 IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. Thromb Res 1987; 45: 791-802 51. Minar E., Ehringer H., Schöfl R.: LACK OF ELEVATION OF ß-THROMBOGLOBULIN AND PLATELET FACTOR 4 IN PLASMA DURING EXERCISE IN PATIENTS WITH CHRONIC PERIPHE-RAL ARTERIAL OCCLUSIVE DISEASE. Klin Wschr 1987; 65: 419-423 52. Minar E., Ehringer H., Ahmadi R., Dudczak R., Porenta G.: PLATELET DEPOSITION AT ANGIOPLASTY SITES UND PLATELET SURVIVAL TIME AFTER PTA IN ILIAC AND FEMORAL ARTERIES: INVESTIGATION WITH INDIUM-111-OXINE LABELLED PLATELETS IN PATIENTS WITH ASA (1.0g/DAY) - THERAPY. Thromb Haemost 1987; 58: 718-723
ARBEITEN NACH DER HABILITATION
53. Zazgornik J., Balcke P., Rokitansky A., Schmidt P., Kopsa H., Minar E., EXCESSIVE MYOCARDIAL CLACINOSIS IN A CHRONIC HEMODIALYZED PATIENT. Klin Wschr 1987; 65: 97-100 54. Kretschmer G., Wenzl E., Huk I., Polterauer P., Ehringer H., Minar E., Schemper M.: DIE ROLLE DER POSTOPERATIVEN ANTIKOAGULANTIENBEHANDLUNG NACH FEMOROPOPLITEALEM VENENBYPASS. Zwischenauswertung einer kontrollierten klinischen Studie. Wr Klin Wschr 1987; 99: 591-595 55. Minar E., Ehringer H.: REPRODUCIBILITY OF PLATELET SURVIVAL TIME MEASUREMENTS IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. Thromb Res 1987; 48: 73-79 56. Zilla P., Fasol R., Deutsch M., Fischlein T., Minar E., Hammerle A., Krupicka O., ENDOTHELIAL CELL SEEDING OF POLYTETRAFLUOROETHYLENE VASCULAR GRAFTS IN HUMANS: A PRELIMINARY REPORT. J Vasc Surg 1987; 6: 535-541 57. Kretschmer G., Wenzl E., Schemper M., Huk I., Konecny U., Marosi L., Minar E.: VEIN BYPASS SURGERY FOR FEMOROPOPLITEAL ARTERIOSCLEROSIS: INFLUENCE OF DIFFERENT RISK FACTORS ON PATIENT SURVIVAL AND THE IMPORTANCE OF ANTICOAGULANT TREATMENT. Eur J Vasc Surgery 1988; 2: 77-81 58. Kretschmer G., Wenzl E., Schemper M., Polterauer P., Ehringer H., Marosi L., Minar E.: INFLUENCE OF POSTOPERATIVE ANTIGOAGULANT TREATMENT ON PATIENT SURVIVAL AFTER FEMOROPOPLITEAL VEIN BYPASS SURGERY. Lancet 1988; 797-799 59. Jung M., Koppensteiner R., Graninger W., Minar E., Kretschmer G., Ehringer H.: HÄMORHEOLOGIE UND AKUTE PHASE REAKTION NACH THROMBEND-ARTERIEKTOMIE DER EXTRACRANIELLEN ARTERIA CAROTIS. Klin Wschr 1988; 66: 379-384 60. Koppensteiner R., Minar E., Marosi L., Ehringer H.: SURVIVAL FOLLOWING AN EXTREMELY HIGH-DOSE OF MITOXANTRONE IN A 73-YEAR OLD FEMALE WITH SMALL CELL BRONCHIAL CARCINOMA J Cancer Res Clin Oncol 1988; 114: 324 (Letter) 61. Koppensteiner R., Minar E., Ahmadi R., Jung M., Ehringer H.: LOW DOSES OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR (r-TPA) FOR LOCAL THROMBOLYSIS IN PERIPHERAL ARTERIES. Radiology 1988; 168: 877 (Letter) 62. Kahls P., Panzer S., Kletter K., Minar E., Stain-Kos M., Walter R., Lechner K., Hinterberger W.: FUNCTIONAL ASPLENIA AFTER BONE MARROW TRANSPLANTATION. A LATE COMPLICATION RELATED TO EXTENSIVE CHRONIC GRAFT-VERSUS-HOST DISEASE. Ann Intern Med 1988; 109: 461-464 63. Minar E., Ehringer H., Jung M., Koppensteiner R., Stümpflen A.: LACK OF INFLUENCE OF LOW-DOSE ACETYLSALICYLIC ACID (100 mg daily) ON PLATELET SURVIVAL TIME, ß-THROMBOGLOBULIN AND PLATELET FACTOR 4 IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. Thromb Res 1988; 52: 219-226 64. Siegert W., Hiddemann W., Koppensteiner R., Büchner Th., Essink M., Huhn D., Jung M., Marosi L., Martin Th., Minar E.: ACCIDENTAL OVERDOSE OF MITOXANTRONE IN THREE PATIENTS. Med Oncol & Tumor Pharmacother 1989; 6: 275-278 65. Koppensteiner R., Jung M., Minar E., Ehringer H.: INCREASED PLATELET AGGREGATION (PA) BUT NO FURTHER HEMO-RHEOLOGICAL ALTERATIONS IN PATIENTS WITH RECENT TRANSIENT ISCHEMIC ATTACKS (TIAs). Clinical Hemorheology 1989; 9: 109-114 66. Minar E., Ehringer H., Dudczak R., Schöfl R., Jung M., Koppensteiner R., Ahmadi R., Kretschmer G.: INDIUM-111-LABELLED PLATELET SCINTIGRAPHY IN CAROTID ATHERO-SCLEROSIS. Stroke 1989; 20: 27-33 67. Minar E., Ehringer H., Ahmadi R., Dudczak R., Leitha Th., Koppensteiner R., Jung M., Stümpflen A.: PLATELET DEPOSITION AT ANGIOPLASTY SITES AND ITS RELATION TO RESTENOSIS AFTER PTA IN HUMAN ILIAC AND FEMOROPOPLITEAL ARTERIES. Radiology 1989; 170: 767-772 Diese Arbeit wurde in KEY Interventional Radiology (Hrsg.: P.R.Mueller, W.R.Castaneda, E.v.Sonnenberg) (1989; 1: 49) zitiert 68. Kyrle P.A., Minar E., Brenner B., Eichler H.G., Heistinger M., Lechner K.: THROMBOXANE A2 AND PROSTACYCLIN GENERATION IN THE MICRO-VASCULATURE OF PATIENTS WITH ATHEROSCLEROSIS-EFFECT OF LOW-DOSE ASPIRIN. Thromb Haemost 1989; 61: 374-377 69. Kretschmer G., Wenzl E., Schemper M., Huk I., Minar E., Marosi L., Polterauer P.: DER EINFLUSS EINER POSTOPERATIVEN ANTIKOAGULANTIENTHERAPIE AUF DAS PATIENTENÜBERLEBEN NACH FEMORO-INFRAINGUINALEM VENENBYPASS. Angio 1989; 11: 77-83 70. Jung M., Kletter K., Dudczak R., Koppensteiner R., Minar E., Kahls P., Stümpflen A., Pokieser P., Ehringer H.: DEEP VEIN THROMBOSIS: SCINTIGRAPHIC DIAGNOSIS WITH IN-111-LABELED MONOCLONAL ANTIFIBRIN ANTIBODIES. Radiology 1989; 173: 469-475 71. Koppensteiner R., Jung M., Minar E., Ehringer H.: HEMORHEOLOGY IN SYSTEMIC ULTRAHIGH-DOSE THROMBOLYTIC THERAPY WITH STREPTO-KINASE AND UROKINASE. Thromb Res 1989; 56: 277-287 72. Panzer S., Haubenstock A., Minar E.: PLATELETS IN HYPERTHYREODISM: STUDIES ON PLATELET COUNTS; MEAN PLATELET VOLUME, 111-INDIUM-LABELED PLATELET KINETICS, AND PLATELET-ASSOCIATED IMMUNO-GLOBULINS G AND M. J Clin Endocrinol Metab 1989; 70: 491-496 73. Speiser W., Speiser P., Minar E., Korninger Ch., Niessner H., Huber K., Schernthaner G., Lechner K.: ACTIVATION OF COAGULATION AND FIBRINOLYSIS IN PATIENTS WITH ARTERIOSCLEROSIS: RELATION TO LOCALIZATION OF VESSEL DISEASE AND RISK FACTORS. Thromb Res 1990; 59: 77-88 74. Speiser W., Mallek R., Koppensteiner R., Stümpflen A., Kapiotis St., Minar E., Ehringer H., Lechner K.: D-DIMER AND TAT MEASUREMENT IN PATIENTS WITH DEEP VENOUS THROMBOSIS: UTILITY IN DIAGNOSIS AND JUDGEMENT OF ANTICOAGU-LANT TREATMENT EFFECTIVENESS. Thromb Haemost 1990; 64: 196-201 75. Koppensteiner R., Minar E., Ehringer H.: EFFECT OF LOVASTATIN ON HEMORHEOLOGY IN TYPE II HYPERLIPO-PROTEINEMIA. Atherosclerosis 1990; 83: 53-58 76. Kretschmer G., Pratschner T., Prager M., Wenzl E., Polterauer P., Schemper M., Ehringer H., Minar E.: ANTIPLATELET TREATMENT PROLONGS SURVIVAL AFTER CAROTID BIFURCATION ENDARTERECTOMY. ANALYSIS OF THE CLINICAL SERIES FOLLOWED BY A CONTROLLED TRIAL. Ann Surg 1990; 211: 317-322 77. Koppensteiner R., Stockenhuber F., Jahn Ch., Balcke P., Minar E., Ehringer H.: CHANGES IN DETERMINANTS OF BLOOD RHEOLOGY DURING TREATMENT WITH HAEMODIALYSIS AND RECOMBINANT HUMAN ERYTHROPOIETIN. Br Med J. 1990; 300: 1626-1627 78. Koppensteiner R., Speiser W., Minar E., Ahmadi R., Ehringer H.: D-DIMER IN LOCAL THROMBOLYTIC THERAPY WITH LOW DOSES OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR (rt-PA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE.
Thromb Haemostas 1990; 64: 192-195 79. Magometschnigg H., Kadletz M., Vodrazka M., Dock W., Grimm M., Grabenwöger M., Minar E., Staudacher M., Fenzl G., Wolner E.: PROSPECTIVE CLINICAL STUDY WITH IN VITRO ENDOTHELIAL CELL LINING OF EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS IN CRURAL REPEAT RECONSTRUCTION. J Vasc Surg 1992; 15: 527-535 80. Kadletz M., Magometschnigg H., Minar E., König G., Grabenwöger M., Grimm IMPLANTATION OF IN VITRO ENDOTHELIALIZED POLYTETRAFLUORO-ETHYLENE GRAFTS IN HUMAN BEINGS - A PRELIMINARY REPORT. J Thorac Cardiovasc Surg 1992; 104: 736-742 81. Katzenschlager R., Koppensteiner R., Minar E., Muhm M., Stümpflen A., Ugurluoglu A., Huk I., Ehringer H.: MAKROEMBOLIE ALS KOMPLIKATION BEI ULTRAHOCHDOSIERTER UROKINASELYSE EINES BIFURKATIONSPROTHESENVERSCHLUSSES. VASA 1993; 22: 355-357 82. Zilla P., Deutsch M., Meinhart J., Puschmann R., Eberl Th., Minar E., Dudczak R., Lugmaier H., Schmidt P., Noszian I., Fischlein T.: CLINICAL IN VITRO ENDOTHELIALIZATION OF FEMOROPOPLITEAL BYPASS GRAFTS: AN ACTUARIAL FOLLOW-UP OVER THREE YEARS. J Vasc Surg 1994; 19: 540-548 83. Minar E., Ahmadi A., Koppensteiner R., Maca Th., Stümpflen A., Ugurluoglu A., COMPARISON BETWEEN HIGH (1000 mg/day) AND LOW DOSE (100 mg/day) ASPIRIN ON RESTENOSIS AFTER FEMOROPOPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY. Circulation 1995; 91: 2167-2173 84. Katzenschlager R., Ugurluoglu A., Ahmadi A., Hülsmann M., Koppensteiner R., Larch E., Maca Th., Minar E., Stümpflen A., Ehringer H.: INCIDENCE OF PSEUDOANEURYSM AFTER DIAGNOSTIC AND THERA-PEUTIC ANGIOGRAPHY. Radiology 1995; 195: 463-466 85. Katzenschlager R., Ahmadi A., Minar E., Koppensteiner R., Maca Th., Pikesch K., Stümpflen A., Ugurluoglu A., Ehringer H.: FEMOROPOPLITEAL ARTERY: INITIAL AND 6-MONTH RESULTS OF COLOR DUPLEX US-GUIDED PERCUTANEOUS TRANSLUMINAL ANGIO-PLASTY. Radiology 1996; 199: 331-334 86. Katzenschlager R., Ahmadi A., Koppensteiner R., Minar E., Stümpflen A., Ugurluoglu A., Ehringer H.: LERICHE - SYNDROM: BEHANDLUNG MIT LOKALER LYSE UND AN-SCHLIESSENDER PERKUTANER TRANSLUMINALER ANGIOPLASTIE. VASA 1996; 25: 180-183 87. Baldt M.M., Zontsich T., Stümpflen A., Fleischmann D., Schneider B., Minar E., SPIRAL - CT - VENOGRAPHY OF THE LOWER EXTREMITY IN DEEP VENOUS THROMBOSIS. Radiology 1996; 200: 423-428 88. Burgmann H., Georgopoulos A., Graninger W., Koppensteiner R., Maca Th., Minar E., Schneider B., Stümpflen A., Ehringer H.: TISSUE CONCENTRATION OF CLINDA-MYCIN AND GENTAMICIN NEAR ISCHEMIC ULCERS WITH TRANSVENOUS INJECTION IN BIER'S ARTERIAL ARREST. Lancet 1996; 348: 781-783 89. Maca Th., Ahmadi A., Derfler K., Hörl W.H., Koppensteiner R., Minar E., Schneider B., Stümpflen A., Ehringer H.: ELEVATED LIPOPROTEIN (a) AND INCREASED INCIDENCE OF RESTENO-SIS AFTER FEMOROPOPLITEAL PTA. RATIONALE FOR THE HIGHER RISK OF RECURRENCE IN FEMALES ? Atherosclerosis 1996; 127: 27-34 90. Gschwandtner M.E., Koppensteiner R., Maca Th., Minar E., Schneider B., Schnürer G., Ehringer H.: SPONTANEOUS LASER DOPPLER FLUX DISTRIBUTION IN ISCHEMIC ULCERS AND THE EFFECT OF PROSTANOIDS: A CROSS OVER STUDY COMPARING THE ACUTE ACTION OF PROSTAGLANDIN E1 AND ILOPROST VS. SALINE. Microvasc. Research 1996; 51: 29-38 91. Muhm M., Claeys L., Huk I., Koppensteiner R., Kyrle P.A., Minar E., Stümpflen A., Ehringer H., Polterauer P.: THROMBOEMBOLIC COMPLICATIONS IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) SHOWING CROSS - REACTIVITY TO A LOW MOLECULAR WEIGHT HEPARINTREAT-MENT WITH ORG 10172 (LOMOPARAN). Wiener Klin Wochenschr 1997; 109: 128-131 92. Eichinger S., Pabinger I., Stümpflen A., Hirschl M., Bialonczyk Ch., Schneider B., Mannhalter Ch., Minar E., Lechner K., Kyrle P.A.: THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT FACTOR V LEIDEN. Thromb Haemostas 1997; 77: 624-628 93. Ugurluoglu A., Katzenschlager R., Ahmadi R., Atteneder M., Koppensteiner R., Lang G., Maca T., Minar E., Schneider B., Stümpflen A., Ehringer H.: ULTRASOUND GUIDED COMPRESSION THERAPY IN 134 PATIENTS WITH IATROGENIC PSEUDOANEURYSMS: ADVANTAGE OF ROUTINE DUPLEX ULTRASOUND CONTROL OF THE PUNCTURE SITE FOLLOWING TRANS-FEMORAL CATHETERIZATION. VASA 1997; 26: 110-116 94. Larch E., Minar E., Ahmadi R., Schnürer G., Schneider B., Stümpflen A., Ehringer H.: VALUE OF COLOR DUPLEX SONOGRAPHY FOR EVALUATION OF TIBIOPERONEAL ARTERIES IN PATIENTS WITH FEMOROPOPLITEAL OBSTRUCTION: A PROSPECTIVE COMPARISON WITH ANTEROGRADE INTRAARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY. J Vasc Surg 1997; 25: 629-636 95. Bounameaux H., Ehringer H., Hulting J., Rasche H., Rapold H.J., Zultak M. and the ADVENT Investigators: A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSA-GATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS. RESULTS OF THE EUROPEAN MULTICENTER ADVENT TRIAL. Thromb Haemost 1997; 78: 997-1002 Diese Arbeit wurde in Interventional Radiology Monitor 1997; 1: 68 zitiert 96. Kretschmer G., Hölzenbein Th., Lammer J., Thurnher S., Minar E., Polterauer P.: THE FIRST 15 MONTHS OF TRANSLUMINAL ABDOMINAL AORTIC ANEURYSM MANAGEMENT: A SINGLE CENTRE EXPERIENCE. Eur J Vasc Endovasc Surg 1997; 14: 24-32 97. Hölzenbein Th., Kretschmer G., Glanzl R., Schön A., Thurnher S., Winkelbauer F., Trubel W., Minar E., Ahmadi A., Huk I., Ingruber H., Ehringer H., Lammer J., Polterauer P.: ENDOVASCULAR AAA TREATMENT: EXPENSIVE PRESTIGE OR ECONO-MIC ALTERNATIVE ? Eur J Vasc Endovasc Surg 1997; 14: 265-272 98. Minar E., Pokrajac B., Ahmadi R., Maca Th., Seitz W., Stümpflen A., Pötter R., BRACHYTHERAPY FOR PROPHYLAXIS OF RESTENOSIS AFTER LONG-SEGMENT FEMOROPOPLITEAL ANGIOPLASTY: PILOT STUDY. Radiology 1998; 208: 173-179 99. Katzenschlager R., Ahmadi A., Minar E., Ugurluoglu A., Atteneder M., Koppensteiner R., Maca Th., Stümpflen A., Ehringer H.: COLOR DUPLEXSONOGRAPHY GUIDED STENT PLACEMENT IN A STENO-SIS OF THE SUPERFICIAL FEMORAL ARTERY. Internat Angiol 1998; 17: 80-82 100. Hölzenbein Th., Kretschmer G., Dorffner R., Thurnher S., Sandner D., Minar E., Lammer J., Polterauer P.: ENDOVASCULAR MANAGEMENT OF "ENDOLEAKS" AFTER TRANS-LUMINAL INFRARENAL ABDOMINAL ANEURYSM REPAIR. Eur J Vasc Endovasc Surg 1998; 16: 208-217 101. Eichinger S., Minar E., Hirschl M., Bialonczyk C., Stain M., Mannhalter C., Stümpflen A., Schneider B., Lechner K., Kyrle P.A.: THE RISK OF EARLY RECUR-RENT VENOUS THROMBOEMBOLISM AFTER ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH THE G20210A TRANSITION IN THE PROTHROMBIN GENE. Thromb Haemost 1999; 81: 14-17 102. Redlich K., Parschalk B., Ehringer H., Minar E.: TICLOPIDINE INDUCED PROLONGED LEUCOPENIA IN A PATIENT WITH IMMUNOCYTOMA AND CHRONIC HEPATITIS C. VASA 1999; 28: 301-303 103. Gschwandtner M.E., Minar E., Ahmadi A., Haumer M., Hülsmann M., Maca T., Schnürer G., Willfort A., Polterauer P., Meissl G., Ehringer H.: IMPACT OF DIFFERENT THERAPEUTIC ALTERNATIVES IN TREATMENT OF SEVERE LIMB ISCHEMIA: EXPERIENCES ON 190 CONSECUTIVE PATIENTS AT A DEPARTMENT OF MEDICAL ANGIOLOGY. VASA 1999; 28:271-278 104. Müller M., Brunner M., Hollenstein U., Joukhadar Ch., Schmid R., Minar E., Ehringer H., Eichler H.G.: PENETRATION OF CIPROFLOXACIN INTO THE INTERSTITIAL SPACE OF INFLAMED FOOT LESIONS IN NON-INSULIN-DEPENDENT DIABETES MELLITUS PATIENTS. Antimicrobial Agents and Chemotherapy 1999; 43: 2056-2058 105. Minar E., Pilger E.: PTA/STENTIMPLANTATION DER ARTERIA CAROTIS: GEFÄHRLICHES EXPERIMENT ODER THERAPIE DER ZUKUNFT? Wien Klin Wochenschr 1999; 111: 495-500 106. Bounameaux H., Ehringer H., Gast A., Hulting J., Rasche H., Rapold H.J., Reber G., Tschopp T.B. on behalf of the ADVENT Investigators: DIFFERENTIAL INHIBITION OF THROMBIN ACTIVITY AND THROMBIN GENERATION BY A SYNTHETIC DIRECT THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) AND UNFRACTIONATED HEPARIN IN PATIENTS WITH DEEP VEIN THROMBOSIS. Thromb Haemost 1999; 81: 498-501 107. Kyrle P.A., Minar E., Hirschl M., Bialonczyk Ch., Stain M., Schneider B., Weltermann A., Speiser W., Lechner K., Eichinger S.: HIGH PLASMA LEVELS OF FACTOR VIII AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM. NEJM 2000; 343: 457-462 108. Stümpflen A., Ahmadi A., Atteneder M., Gschwandtner M., Hofmann S., Maca Th., Schnürer G., Minar E.: EFFECTS OF TRANSVENOUS REGIONAL GUANETHIDINE BLOCK IN THE TREATMENT OF CRITICAL FINGER ISCHEMIA. Angiology 2000; 51: 115-122 109. Minar E., Pokrajac B., Maca Th., Ahmadi R., Fellner C., Mittlböck M., Seitz W., Wolfram R., Pötter R.: ENDOVASCULAR BRACHYTHERAPY FOR PROPHYLAXIS OF RESTENOSIS AFTER FEMOROPOPLITEAL ANGIOPLASTY: RESULTS OF A PROSPECTIVE, RANDOMIZED STUDY. Circulation 2000; 102: 2694-2699 110. Minar E., Wolfram R., Pokrajac B.: ENDOVASCULAR BRACHYTHERAPY AND LATE THROMBOTIC OCCLU-SION. Circulation 2000; 102: e175-176 (letter) 111. Katzenschlager R., Burgmann H., Ehringer H., Minar E.: VASOSPASM: A RARE MANIFESTATION OF HOMOCYSTEINURIA. VASA 2000; 29: 84-86 112. Katzenschlager R., Ahmadi A., Atteneder M., Ugurluoglu A., Koppensteiner R., Minar E., Ehringer H. COLOUR DUPLEX SONOGRAPHY-GUIDED LOCAL LYSIS OF OCCLUSIONS IN THE FEMORO-POPLITEAL REGION. Int Angiol 2000; 19: 250-254 113. Bucek R.A., Schnürer G., Ahmadi A., Polterauer P., Kretschmer G., Minar E.: THE ROLE OF ANTITHROMBOTIC THERAPY ON THE PATENCY OF PERI-PHERAL BYPASSES. VASA 2000; 29: 163-167 114. Bucek R.A., Maca T., Ahmadi R., Minar E.: TEMPORARY VENA CAVA FILTERS DO NOT ALWAYS PREVENT FATAL PULMONARY EMBOLISM. VASA 2000; 29: 292-294 115. Bucek R.A., Schnürer G., Ahmadi A., Maca T., Meissl G., Minar E.: A SEVERE CASE OF VASCULAR THORACIC OUTLET SYNDROME. Wien Klin Wochenschr 2000; 112: 973-977 116. Pokrajac B., Minar E., Pötter R., Maca Th., Fellner C., Mittlböck M., Ahmadi R., INTRAARTERIAL 192-IR HDR BRACHYTHERAPY FOR PROPHYLAXIS OF RESTENOSIS AFTER FEMOROPOPLITEAL PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY: THE PROSPECTIVE RANDOMIZED VIENNA-2-TRIAL. RADIO-THERAPY PARAMETERS AND RISK FACTOR ANALYSIS. Int J Rad Onc Biol Phys 2000; 48: 923-931 117. Haumer M., Minar E.: PERIINTERVENTIONELLE MEDIKAMENTÖSE THERAPIE BEI PTA DER SUPRAAORTISCHEN GEFÄSSE. Der Radiologe 2000; 40: 1172-1182 118. Ziegler S., Schillinger M., Maca Th., Minar E.: POSTTHROMBOTIC SYNDROME AFTER PRIMARY EVENT OF DEEP VENOUS THROMBOSIS TEN TO TWENTY YEARS AGO: Thromb Res 2001; 101: 23-33 119. Bucek R.A., Quehenberger P., Feliks I., Handler S., Reiter M., Minar E.: RESULTS OF A NEW RAPID D-DIMER ASSAY (CARDIAC D-DIMER) IN THE DIAGNOSIS OF DEEP VEIN THROMBOSIS. Thromb Res 2001; 103: 17-23 120. Ahmadi R., Schillinger M., Haumer M., Willfort A., Minar E.: CAROTID STENTING IN A CASE OF COMBINED KINKING AND STENOSIS. Cardiovasc Inter Rad 2001; 24: 197-199 121. Al-Awami M., Schillinger M, Gschwandtner M, Maca Th, Haumer M, Minar E.: LOW LEVEL LASER TREATMENT OF PRIMARY AND SECONDARY RAYNAUD'S PHENOMENON. VASA 2001; 30: 281-284 122. Bucek R.A., Kos T., Schober E., Zontsich T., Haumer M., Pötzi C., Minar E.: ULTRASOUND WITH LEVOVIST IN THE DIAGNOSIS OF SUSPECTED CALF VEIN THROMBOSIS. Ultrasound Med Biol 2001; 27: 455-460 123. Bucek R.A., Schnürer G., Haumer M., Reiter M., Ahmadi A., Minar E. LONG TERM RESULTS OF SYSTEMIC THROMBOLYSIS THERAPY IN AORTOILIAC OCCLUSIVE DISEASE. VASA 2001; 30: 212-218 124. Wolfram R.M., Pokrajac B., Ahmadi R., Fellner C., Gyöngyösi M., Haumer M., Bucek R., Pötter R., Minar E. ENDOVASCULAR BRACHYTHERAPY FOR PROPHYLAXIS OF RESTENOSIS AFTER LONG-SEGMENT FEMOROPOPLITEAL STENTING: PILOT STUDY. Radiology 2001; 220: 724-729 125. Dempfle C.E., Schraml M., Besenthal I., Hansen R., Gehrke J., Korte W, Risch M., Quehenberger P., Handler S, Minar E, Schulz I., Zerback R. MULTICENTRE EVALUATION OF A NEW POINT-OF-CARE TEST FOR THE QUANTITATIVE DETERMINATION OF D-DIMER. Clin Chim Acta 2001; 307: 211-218 126. Exner M., Alt E., Hermann M., Hofbauer R., Kapiotis S., Quehenberger P., Speiser W., Minar E., Gmeiner B. P-HYDROXYPHENYLACETALDEHYDE, THE MAJOR PRODUCT OF TYROSINE OXIDATION BY THE ACTIVATED MYELOPEROXIDASE SYSTEM CAN ACT AS AN ANTIOXIDANT IN LDL. FEBS Lett 2001; 490: 28-31 127. Schillinger M, Haumer M, Schlerka G., Mlekusch W, Exner M., Ahmadi R, Minar E: RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN THE FEMOROPOPLITEAL SEGMENT: THE ROLE OF INFLAMMATION.
J Endovasc Ther 2001;8: 477-483 128. Ahmadi R., Willfort A., Lang W., Schillinger M., Alt E., Gschwandtner M.E., Haumer M., Maca Th., Ehringer H., Minar E. CAROTID ARTERY STENTING: EFFECT OF LEARNING CURVE AND INTERMEDIATE-TERM MORPHOLOGICAL OUTCOME. J Endovasc Ther 2001;8:539-546 129. Schillinger M., Haumer M., Mlekusch W., Schlerka G., Ahmadi R., Minar E. PREDICTING RENAL FAILURE AFTER BALLOON ANGIOPLASTY IN HIGH- RISK PATIENTS. J Endovasc Ther 2001;8:609-614 130. Schillinger M., Haumer M., Schillinger S., Ahmadi R., Minar E. RISK STRATIFICATION FOR SUBCLAVIAN ARTERY PTA: IS THERE AN INCREASED RATE OF RESTENOSIS AFTER STENT IMPLANTATION? J Endovasc Ther 2001;8:550-557 131. Exner M.*, Schillinger M.*, Minar E., Mlekusch W., Schlerka G., Haumer M., Mannhalter C., Wagner O. * both authors contributed equally to the study HEME OXYGENASE – 1 GENE PROMOTER MICROSATELLITE POLY-MORPHISM IS ASSOCIATED WITH RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY. J Endovasc Ther 2001;8: 433-440 132. Haumer M, Atteneder M, Ahmadi R, Schillinger M, Minar E: COADMINISTRATION OF LOW-DOSE UROKINASE AND ABCIXIMAB IN THROMBOLYSIS FOR LOWER LIMB ISCHEMIA.A SAFETY STUDY Thromb Res 2001; 103(Suppl ): S143-149 133. Joukadar Ch, Klein N, Frossard M, Minar E, Stass H, Lackner E, Herrmann M, Riedmüller E, Müller M: ANGIOPLASTY INCREASES TARGET SITE CONCENTRATIONS OF CIPROFLOXACIN IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Clin.Pharmacol Ther. 2001;70:532-539 IF 5.06 134. Ahmadi R., Schillinger M., Sabeti S., Loewe C, Mlekusch W., Haumer M, Banyai M, Lammer J., Minar E. RENAL ARTERY PTA AND STENT IMPLANTATION: IMMEDIATE AND LONGTERM CLINICAL AND MORPHOLOGICAL OUTCOME. Wien Klin Wochenschr . 2002;114:21-27 135. Bucek R.A., Koca N., Reiter M., Haumer M, Zontsich T., Minar E. ALGORITHMS FOR THE DIAGNOSIS OF DEEP VEIN THROMBOSIS IN PATIENTS WITH LOW CLINICAL PRE-TEST PROBABILITY. Thromb Res 2002;105(1):43-47 136. Pokrajac B, Minar E, Kirisits Ch, Pötter R: PRESENT STATUS OF ENDOVASCULAR BRACHYTHERAPY IN PERIPHERAL ARTERIES Herz 2002;27:56-61 IF 0.97 137. Bucek R.A., Hudak P., Schnürer G., Ahmadi A., Wolfram R.M., Minar E.: CLINICAL LONG-TERM RESULTS OF PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. VASA 2002;31: 36-42 138. Schillinger M., Exner M., Mlekusch W., Haumer M., Ahmadi R., Rumpold H., Wagner O., Minar E. BALLOON ANGIOPLASTY AND STENT IMPLANTATION INDUCE A VASCULAR INFLAMMATORY RESPONSE. J Endovasc Ther 2002; 9:59-66 139. Maca T.H., Ahmadi R., Derfler K., Ehringer H., Gschwandtner M.E., Hörl W.H., Katzenschlager R., Müller-Knespel E., Koppensteiner R., Schneider B., Stümpflen A., Ugurluoglu A., Minar E. INFLUENCE OF LIPOPROTEIN (a) ON RESTENOSIS AFTER FEMORO-POPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN TYPE 2 DIABETIC PATIENTS. Diabetic Med 2002;19:300-306 140. Ahmadi R., Schillinger M., Maca Th., Minar E. FEMOROPOPLITEAL ARTERIES: IMMEDIATE AND LONG-TERM RESULTS WITH A DACRON-COVERED STENT-GRAFT Radiology 2002;223:345-50 141. Schillinger M, Exner M, Mlekusch W, Rumpold H, Ahmadi R, Sabeti S, Wagner O, Minar E: FIBRINOGEN PREDICTS RESTENOSIS AFTER ENDOVASCULAR TREATMENT OF THE ILIAC ARTERIES Thromb Haemost 2002;87:959-965 IF 4.36 142. Schillinger M., Haumer M., Schillinger S., Mlekusch W., Ahmadi R., Minar E. OUTCOME OF INTERVENTIONAL VS. CONSERVATIVE TREATMENT OF SUBCLAVIAN ARTERY STENOSIS. J Endovasc Ther 2002; 9:139-46 143. Pokrajac B, Schmid R,Kirisits C,Mock U, Fellner C, Wambersie A, Pötter R, Minar E: POSSIBLE IMPACT OF IRIDIUM-192 SOURCE CENTERING ON RESTENOSIS RATE AFTER FEMOROPOPLITEAL ANGIOPLASTY AND ENDOVASCULAR BRACHYTHERAPY IN VIENNA-2 STUDY. Radiother Oncol 2002;63:97-102 IF 2.84 144. Schillinger M., Domanovits H., Ignatescu M., Exner M., Bayegan K., Sedivy R., Polterauer P., Laggner A.N., Minar E., Kostner K. LIPOPROTEIN (a) IN PATIENTS WITH AORTIC ANEURYSMS. J Vasc Surg 2002;36:25-30 145. Willfort A, Ahmadi R, Gschwandtner ME, Haumer M, Lang W, Minar E: SINGLE CENTER EXPERIENCE WITH CAROTID STENT RESTENOSIS J Endovasc Ther 2002;9:299-307 IF 2.58 146. Al-Awami M., Schillinger M., Maca T., Gschwandtner M., Bieglmayer C., Wagner O., Minar E. HOMOCYSTEINE LEVELS IN PATIENTS WITH RAYNAUD'S PHENOMENON. VASA 2002;31:87-90 147. Rezaie-Majd A., Maca Th, Bucek R, Valent P, Müller M.R, Husslein P, Kashanipour A., Minar E, Baghestanian M: SIMVASTATIN REDUCES THE EXPRESSION OF CYTOKINES IL-6, IL-8, AND MCP-1 IN CIRCULATING MONOCYTES FROM HYPERCHOLESTEROLEMIC PATIENTS. Arterioscl Thromb Vasc Biol 2002;22:1194-99 148. Schillinger M., Exner M., Mlekusch W., Haumer M., Ahmadi R., Rumpold H., Wagner O., Minar E. INFLAMMATORY RESPONSE TO STENT IMPLANTATION: DIFFERENCES OF FEMORAL, ILIAC AND CAROTID ARTERIES. Radiology 2002;224:529-535 149. Sabeti S, Schillinger M, Mlekusch W, Ahmadi R, Minar E: REDUCTION IN RENAL FUNCTION AFTER RENAL ARTERIOGRAPHY AND AFTER RENAL ARTERY ANGIOPLASTY Eur J Vasc Endovasc Surg 2002;24: 156-160 IF 1.55 150. Mlekusch W., Schillinger M., Sabeti S., Maca Th., Ahmadi R., Minar E. CLINICAL OUTCOME AND PROGNOSTIC FACTORS FOR ISCHEMIC ULCERS TREATED WITH PTA IN LOWER LIMBS. Eur J Vasc Endovasc Surg 2002;24:176-81 151. Schillinger M., Exner M., Mlekusch W., Domanovits H., Huber K., Mannhalter C., Wagner O., Minar E. HEME OXYGENASE-1 GENE PROMOTER POLYMORPHISM IS ASSOCIATED WITH ABDOMINAL AORTIC ANEURYSM Thromb Res 2002;106:131-136 IF 1.49 152. Graninger M., Grassberger M., Galehr E., Huemer F., Gruschina E., Minar E., BIOSURGICAL DEBRIDEMENT FACILITATES HEALING OF CHRONIC SKIN ULCERS Arch Intern Med 2002 ;162:1906-07 IF 6.75 153. Schillinger M., Exner M., Mlekusch W., Ahmadi R., Rumpold H., Mannhalter C., Wagner O., Minar E. HEME OXYGENASE-1 GENOTYPE IS A VASCULAR ANTI-INFLAMMATORY FACTOR AFTER BALLOON ANGIOPLASTY. J Endovasc Ther 2002;9: 385-394 IF 2.58 154. Bucek R.A., Reiter M., Koppensteiner I., Ahmadi R., Minar E., Lammer J. B-FLOW EVALUATION OF CAROTID ARTERIAL STENOSIS : INITIAL EXPERIENCE Radiology 2002; 225: 295-299 IF 4.76 155. Schillinger M, Exner M, Mlekusch W, Rumpold H, Ahmadi R, Sabeti S, Haumer M,Wagner O, Minar E VASCULAR INFLAMMATION AND PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE FEMOROPOPLITEAL ARTERY: ASSOCIATION WITH RESTENOSIS Radiology 2002; 225:21-26 IF 4.84 156. Nanobashvili J, Sautner T, Domenig C, Huk I, Minar E, Lammer J, Cejna M, Hölzenbein T, Kretschmer G, Polterauer P: SUPRAAORTALE ARTERIELLE VERSCHLUSSKRANKHEIT: ERGEBNISSE DER REKONSTRUKTION AN DER PROXIMALEN A. SUBCLAVIA UND CAROTIS Chir.Praxis 2002;60: 461-474 157. Nanobashvili J, Sautner T, Domenig C, Huk I, Minar E, Lammer J, Cejna M, Hölzenbein T, Kretschmer G, Polterauer P: SUPRAAORTALE ARTERIELLE VERSCHLUSSKRANKHEIT: OPERATIVE UND ENDOVASKULÄRE BEHANDLUNG VON CAROTIS-INTERNA-STENOSEN Chir.Praxis 2002;60: 675-686 158. Bucek R, Reiter M, Quehenberger P, Minar E: C-REACTIVE PROTEIN IN THE DIAGNOSIS OF DEEP VEIN THROMBOSIS Brit.J.Hematol 2002;119:385-389 IF 3.05 159. Schillinger M., Mlekusch W., Haumer M., Sabeti S., Maca Th., Minar E. RELATION OF SMALL ARTERY COMPLIANCE AND LIPOPROTEIN (a) IN PATIENTS WITH ATHEROSCLEROSIS. Am J Hypertens 2002; 15:980-985 160. Eichinger S, Weltermann A, Mannhalter Ch, Minar E, Bialonczyk Ch, Hirschl M, Schönauer V, Lechner K, Kyrle PA: THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN AND A FIRST SPONTANEOUS VENOUS THROMBOEMBOLISM Arch Intern Med 2002; 162: 2357-2360 IF 6.75 161. Ahmadi R., Schillinger M., Lang W., Mlekusch W., Sabeti S., Minar E. CAROTID ARTERY STENTING IN OLDER PATIENTS: IS AGE A RISK FACTOR FOR POOR OUTCOME ? J Endovasc Ther 2002;9:559-565 IF 2.58 162. Funovics MA, Lackner B, Cejna M, Peloschek P, Sailer J, Philipp MO, Maca T, Ahmadi A, Minar E, Lammer J: PREDICTORS OF LONG-TERM RESULTS AFTER TREATMENT OF ILIAC ARTERY OBLITERATION BY TRANSLUMINAL ANGIOPLASTY AND STENT DEPLOYMENT Cardiovasc Intervent Radiol 2002;25:397-402 IF 0.97 163. Mlekusch W., Schillinger M., Haumer M., Maca Th., Gschwandtner M.E., Minar E. OUTCOME OF CONSERVATIVE MEDICAL TREATMENT OF PATIENTS WITH INFRARENAL ABDOMINAL AORTIC ANEURYSMS Wien klin Wochenschr 2002; 114: 898-903 164. Reiter M, Bucek R, Stümpflen A, Dirisamer A, Minar E: PROSTANOIDS IN THE TREATMENT OF INTERMITTENT CLAUDICATION – A META-ANALYSIS VASA 2002 ;31:219-224 IF 0.43 165. Ziegler S, Maca Th, Alt E, Speiser W, Schneider B, Minar E: MONITORING OF ANTIPLATELET THERAPY WITH THE PFA-100 IN PERIPHERAL ANGIOPLASTY PATIENTS Platelets 2002;13: 493-497 IF 1.48 166. Schillinger M., Domanovits H., Mlekusch W., Bayegan K., Khanakah G., Laggner A.N., Minar E., Stanek G. ANTI CHLAMYDIA ANTIBODIES IN PATIENTS WITH THORACIC AND ABDOMINAL AORTIC ANEURYSMS Wien Klin Wochenschr 2002;114:972-977 167. Ahmadi R., Ugurluoglu A., Schillinger M., Katzenschlager R., Sabeti S., Minar E. DUPLEX-ULTRASOUND GUIDED FEMOROPOPLITEAL PTA: INITIAL AND 12 MONTH RESULTS FROM A CASE CONTROLLED STUDY J Endovasc Ther 2002;9:873-881 IF 2.58 168. Sabeti S, Schillinger M, Mlekusch W, Haumer M, Ahmadi R, Minar E: TREATMENT OF SUBCLAVIAN-AXILLARY VEIN THROMBOSIS: LONG-TERM OUTCOME OF ANTICOAGULATION VERSUS SYSTEMIC THROMBOLYSIS Thromb Res 2003;108:279-285 IF 1.49 169. Bucek R,Reiter M,Quehenberger P, Weltermann A, Kyrle PA, Minar E: THROMBUS PRECURSER PROTEIN,ENDOGENOUS THROMBIN POTENTIAL, VON-WILLEBRAND FACTOR AND ACTIVATED FACTOR VII IN SUSPECTED DEEP VEIN THROMBOSIS: IS THERE A PLACE FOR NEW PARAMETERS? Br.J Haematol. 2003;120:123-128 IF 3.05 170. Reiter M, Bucek R, Koca N, Heger J, Minar E: IDRAPARINUX AND LIVER ENZYMES: OBSERVATIONS AT THE PERSIST TRIAL Blood Coagul Fibrinolysis 2003;14:61-65 IF 1.59 171. Weltermann A, Eichinger S, Bialonczyk C, Minar E, Hirschl M, Quehenberger P, Schönauer V, Kyrle PA: THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AMONG PATIENTS WITH HIGH FACTOR IX LEVELS. Thromb Haemostas 2003;1:28-32 IF 4.36 172. Reiter M, Bucek RA, Koca N, Dirisamer A, Minar E: DEEP VEIN THROMBOSIS AND SYSTEMIC INFLAMMATORY RESPONSE: A PILOT TRIAL Wien.klin.Wochenschr. 2003 ; 115:111-114 IF 0.49 173. Minar E, Pokrajac B, Budinsky A, Pötter R: ENDOVASCULAR BRACHYTHERAPY IN PERIPHERAL ARTERIES VASA 2003;32:3-9 174. Schönauer V, Kyrle PA, Weltermann A, Minar E, Bialonczyk Ch, Hirschl M, Quehenberger P, Schneider B, Partsch H, Eichinger S: SUPERFICIAL THROMBOPHLEBITIS AND RISK FOR RECURRENT VENOUS THROMBOEMBOLISM J Vasc Surg 2003;37:834-38 IF 3.46 175. Rezaie-Majd A, Prager G, Bucek R, Schernthaner G, Maca Th, Kress H, Valent P, Binder B, Minar E, Baghestanian M: SIMVASTATIN REDUCES THE EXPRESSION OF ADHESION MOLECULES IN CIRCULATING MONOCYTES FROM HYPERCHOLESTEROLEMIC PATIENTS Arterioscl Thromb Vasc Biol 2003;23:397-403 IF 6.35 176. Steiner S,Ahmadi R, Willfort A, Lang W, Minar E, Kopp Ch: HEMOSTATIC MARKERS WITH BOLUS VERSUS PROLONGED HEPARIN AFTER CAROTID ARTERY STENTING Thromb Res 2003;109:23-29 IF 1.44 177. Pokrajac B, Wolfram R, Lileg B, Minar E: ENDOVASCULAR BRACHYTHERAPY IN PERIPHERAL ARTERIES: SOLUTION FOR RESTENOSIS OR FALSE HOPE? Curr Treat Options Cardiovasc Med 2003;5:121-126 178. Pokrajac B, Lileg B, Cejna M, Minar E: GAMMA ENDOVASCULAR BRACHYTHERAPY FOR RESTENOSIS PREVENTION AFTER FEMOROPOPLITEAL ANGIOPLASTY AND TRANSJUGULAR PORTOSYSTEMIC SHUNT REVISION Recent Res Devel Radiol 2003; 1: 189-198 179. Kopp HP, Kopp CW, Festa A, Krzyzanowsky K, Kriwanek S, Minar E, Roka R, Schernthaner G: IMPACT OF WEIGHT LOSS ON INFLAMMATORY PROTEINS AND THEIR ASSOCIATIONS TO THE INSULIN RESISTANCE SYNDROME IN MORBIDLY OBESE PATIENTS Arterioscl Thromb Vasc Biol 2003;23:1042-1047 IF 6.35 180. Schillinger M, Exner M, Mlekusch W, Haumer M, Rumpold H, Ahmadi R, Sabeti S, Wagner O, Minar E: ENDOVASCULAR RECANALISATION BELOW THE KNEE: 6-MONTH RESULTS AND PREDICTIVE VALUE OF C- REACTIVE PROTEIN LEVEL Radiology 2003;227:419-425 IF 4.84 181. Schillinger M, Exner M, Mlekusch W, Rumpold H, Ahmadi R, Sabeti S, Lang W, Wagner O, Minar E ACUTE PHASE RESPONSE AFTER STENT IMPLANTATION IN THE CAROTID ARTERY: ASSOCIATION WITH 6 MONTH INSTENT – RESTENOSIS Radiology 2003; 227:516-521 IF 4.84 182. Schillinger M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Minar E: ANGIOPLASTY AND ELECTIVE STENTING OF DE NOVO VERSUS RECURRENT FEMOROPOPLITEAL LESIONS: 1-YEAR FOLLOW-UP J Endovasc Ther 2003;10: 288-297 IF 2.58 183. Bucek R, Reiter M, Dirisamer A, Haumer M, Fritz A, Minar E, Lammer J: THREE-DIMENSIONAL COLOR DOPPLER SONOGRAPHY IN CAROTID ARTERY STENOSIS Am J Neuroradiol 2003;24:1294-99 IF 2.46 184. Kopp CW, Kopp HP, Steiner S, Kriwanek S, Krzyzanowska K, Bartok A, Roka R, Minar E, Schernthaner G: WEIGHT LOSS REDUCES TISSUE FACTOR IN MORBIDLY OBESE PATIENTS Obes Res 2003;11: 950-56 IF 3.41 185. Kopp CW, Steiner S, Priglinger U, Christ G, Probst P, Maurer G, Minar E, Huber K: PARAMETERS OF THE TISSUE FACTOR PATHWAY WITH COUMADIN/DIPYRIDAMOL VERSUS TICLOPIDINE AS ADJUNCT ANTITHROMBOTIC-DRUG REGIMEN IN CORONARY ARTERY STENTING Blood Coagulation and Fibrinolysis 2003;14:379-386 IF 1.59 186. Schillinger M, Exner M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Wagner O, Minar E: RESTENOSIS AFTER FEMOROPOPLITEAL PTA AND ELECTIVE STENT IMPLANTATION: PREDICTIVE VALUE OF MONOCYTE COUNTS J Endovasc Ther 2003;10:557-565 IF 2.58 187. Eichinger S, Minar E, Bialonczyk Ch, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA: D-DIMER LEVELS AND RISK OF RECURRENT VENOUS THROMBOEMBOLISM JAMA 2003;290:1071-74 IF 21.456 188. Marculescu R, Mlekusch W, Exner M, Sabeti S, Michor St, Rumpold H, Mannhalter Ch, Minar E, Wagner O, Schillinger M: INTERLEUKIN-1 CLUSTER COMBINED GENOTYPE AND RESTENOSIS AFTER BALLOON ANGIOPLASTY Thromb Haemost 2003;90:491-500 IF 4.95 189. Doweik L, Maca Th, Schillinger M, Budinsky A, Sabeti S, Minar E: FIBRINOGEN PREDICTS MORTALITY IN HIGH RISK PATIENTS WITH PERIPHERAL ARTERY DISEASE Eur J Vasc Endovasc Surg 2003;26:381-386 IF 1.55 190. Joukhadar Ch, Stass H, Müller-Zellenberg U, Lackner E, Kovar F, Minar E, Müller M: PENETRATION OF MOXIFLOXACIN INTO HEALTHY AND INFLAMED SUBCUTANEOUS ADIPOSE TISSUES IN HUMANS Antimicrobial Agents and Chemotherapy 2003;47:3099-3101 IF 4.21 191. Bucek RA, Reiter M, Quehenberger P, Minar E, Baghestanian M: THE ROLE OF SOLUBLE CELL ADHESION MOLECULES IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS Blood Coagulation and Fibrinolysis 2003;14: 653-57 IF 1.59 192. Steiner S, Seidinger D, Huber K, Minar E, Kopp Ch: EFFECT OF GLYCOPROTEIN IIB/IIIA ANTAGONIST ABCIXIMAB ON MONOCYTE-PLATELET AGGREGATES AND TISSUE FACTOR EXPRESSION Arterioscl Thromb Vasc Biol 2003;23:1697-1702 IF 6.79 193. Ziegler S, Brunner M, Eigenbauer E, Minar E: LONG-TERM OUTCOME OF PRIMARY RAYNAUD S PHENOMENON AND ITS CONVERSION TO CONNECTIVE TISSUE DISEASE. A 12-YEAR RETROSPECTIVE PATIENT ANALYSIS. Scand J Rheumatol 2003;32:343-347 IF 2.00 194. Mlekusch W, Schillinger M, Exner M, Sabeti S, Mannhalter Ch, Minar E, Wagner O: PLASMINOGEN ACTIVATOR INHIBITOR-1 AND OUTCOME AFTER FEMOROPOPLITEAL ANGIOPLASTY: ANALYSIS OF GENOTYPE AND PLASMA LEVELS Thromb Haemost 2003 ;90:717-23 IF 4.35 195. Li S, Dudczak R, Koller E, Baghestanian , Ghannadan M, Minar E, Pirich Ch, Angelberger P, Virgolini I, Li M, Valent P: EFFECT OF STATINS ON LIPOPROTEIN RECEPTOR EXPRESSION IN CELL LINES FROM HUMAN MAST CELLS AND BASOPHILS Eur J Clin Pharmacol 2003;59: 507-16 IF 1.96 196. Schillinger M, Exner M, Amighi J, Mlekusch W, Sabeti S, Rumpold H, Wagner O, Minar E: JOINT EFFECTS OF C-REACTIVE PROTEIN AND GLYCATED HEMOGLOBIN IN PREDICTING FUTURE CARDIOVASCULAR EVENTS OF PATIENTS WITH ADVANCED ATHEROSCLEROSIS Circulation 2003; 108:2323-2328 IF 11.16 197. Kopp CW, Steiner S, Nasl Ch, Seidinger D, Mlekusch I, Lang W, Bartok A, Ahmadi R, Minar E: ABCIXIMAB REDUCES MONOCYTE TISSUE FACTOR AFTER CAROTID ANGIOPLASTY AND STENTING: ROLE OF MONOCYTE PLATELET CROSS TALK IN CEREBRAL MICROEMBOLISATION Stroke 2003; 34: 2560-67 IF 5.23 198. Mlekusch W, Schillinger M, Sabeti S, Nachtmann T, Lang W, Ahmadi R, Minar E: HYPOTENSION AND BRADYCARDIA AFTER ELECTIVE CAROTID STENTING: FREQUENCY AND RISK FACTORS J Endovasc Ther 2003; 10:851-59 IF 2.63 199. Bartok A, Rand Th, Minar E: PARKES-WEBER-SYNDROM IN A 63-YEAR-OLD MALE PATIENT J Kardiol 2003;10: 345-47 200. Katzenschlager R, Ugurluoglu A, Minar E, Hirschl M: LIPOSOMAL HEPARIN-SPRAYGEL IN COMPARISON WITH SUBCUTANEOUS LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH SUPERFICIAL VENOUS THROMBOSIS. A RANDOMISED, CONTROLLED, OPEN MULTICENTER STUDY J Kardiol 2003; 10:375-78 201. Bucek RA, Puchner St, Reiter M, Dirisamer A, Minar E, Lammer J: LONG-TERM FOLLOW-UP AFTER RENAL ARTERY STENTING Wien. klin.Wochenschr. 2003;115:788-92 0.77 202. Kopp CW, Hölzenbein T, Steiner S, Marculescu R, Bergmeister H, Seidinger D, Mosberger I, Kaun Ch, Cejna M, Horvath R, Wojta J, Maurer G, Binder BR, Breuss JM, Ecker RC, De Martin R, Minar E: INHIBITION OF RESTENOSIS BY TISSUE FACTOR PATHWAY INHIBITOR: IN VIVO AND IN VITRO EVIDENCE FOR SUPPRESSED MONOCYTE CHEMOATTRACTION AND REDUCED GELATINOLYTIC ACTIVITY Blood 2004;103:1653-61 IF 10.12 203. Krestan CR, Klein N, Fleischmann D, Kaneider A, Novotny C, Kreuzer S, Riedl C, Minar E, Janata K, Herold CJ: VALUE OF NEGATIVE SPIRAL-CT ANGIOGRAPHY IN PATIENTS WITH SUSPECTED ACUTE PE : ANALYSIS OF PE OCCURENCE AND OUTCOME Eur Radiol 2004;14:93-98 IF 1.97 204. Ziegler S, Alt E, Brunner M, Speiser W, Minar E: INFLUENCE OF SYSTEMIC INFLAMMATION ON EFFICIENCY OF ANTIPLATELET THERAPY IN PAOD PATIENTS Ann Hematol 2004;83:92-94 IF 1.24 205. Sabeti S, Schillinger M, Mlekusch W, Nachtmann T, Lang W, Ahmadi R, Minar E: CONTRALATERAL HIGH GRADE CAROTID ARTERY STENOSIS OR OCCLUSION IS NOT ASSOCIATED WITH INCREASED RISK FOR POOR NEUROLOGICAL OUTCOME AFTER ELECTIVE CAROTID STENT PLACEMENT Radiology 2004;230: 70-76 IF 4.81 206. Amighi J, Sabeti S, Schlager O, Mlekusch W, Exner M, Lalouschek W, Ahmadi R, Minar E; Schillinger M: LOW SERUM MAGNESIUM PREDICTS NEUROLOGICAL EVENTS IN PATIENTS WITH ADVANCED ATHEROSCLEROSIS Stroke 2004;35:22-27 IF 5.23 207. Mlekusch W, Exner M, Schillinger M, Sabeti S, Mannhalter Ch, Minar E, Wagner O: E-SELECTIN AND RESTENOSIS AFTER FEMOROPOPLITEAL ANGIOPLASTY: PROGNOSTIC IMPACT OF THE SER128ARG GENOTYPE AND PLASMA LEVELS Thromb Haemost 2004;91:171-79 IF 4.95 208. Eichinger S, Weltermann A, Minar E, Stain M, Schönauer V, Schneider B, Kyrle PA: SYMPTOMATIC PULMONARY EMBOLISM AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM Arch Intern Med 2004;164:92-96 IF 6.76 209. Eichinger S, Schönauer V, Weltermann A, Minar E, Bialonczyk Ch, Hirschl M, Schneider B, Quehenberger P, Kyrle PA: THROMBIN ACTIVABLE FIBRINOLYSIS INHIBITOR( TAFI) AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM Blood 2004; 103:3773-76 IF 10.12 210. Schillinger M, Mlekusch W, Wolfram R, Budinsky A, Exner M, Rumpold H, Wagner O, Pokrajac B, Pötter R, Minar E: ENDOVASCULAR BRACHYTHERAPY: EFFECT ON ACUTE INFLAMMATORY RESPONSE AFTER PERCUTANEOUS FEMOROPOPLITEAL ARTERIAL INTERVENTIONS Radiology 2004;230 ;556-560 IF 4.81 211. Amighi J, Sabeti S, Schlager O, Francesconi M, Ahmadi R, Minar E, Schillinger M: OUTCOME OF CONSERVATIVE THERAPY OF PATIENTS WITH SEVERE INTERMITTENT CLAUDICATION Eur J Vasc Endovasc Surg 2004;27:254-58 IF 1.77 212. Reiter M, Bucek R, Stümpflen A, Minar E: PROSTANOIDS FOR INTERMITTENT CLAUDICATION Cochrane Database Syst Rev 2004;1: CD000986 213. Schillinger M, Exner M, Mlekusch W, Amighi J , Sabeti S, Schlager O, Wagner O, Minar E: SERUM ALBUMIN PREDICTS CARDIAC ADVERSE EVENTS IN PATIENTS WITH ADVANCED ATHEROSCLEROSIS – INTERRELATION WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS Thromb Haemost 2004 ;91: 610-18 IF 4.95 214. Schillinger M, Exner M, Minar E, Mlekusch W,Müllner M, Mannhalter Ch, Bach F, Wagner O: HEME OXYGENASE-1 GENOTYPE AND RESTENOSIS AFTER BALLOON ANGIOPLASTY: A NOVEL VASCULAR PROTECTIVE FACTOR J Am Coll Cardiol 2004;43:950-57 IF 7.60 215. Bucek RA, Puchner St, Reiter M, Dirisamer A, Minar E, Lammer J: MULTI-DETECTOR CT ANGIOGRAPHY WITH PERFUSION ANALYSIS IN THE SURVEILLANCE OF RENAL ARTERY STENTS J Endovasc Ther 2004;11:139-43 IF 2.63 216. Schillinger M, Minar E: STENT IMPLANTATION FOR THE TREATMENT OF BILATERAL LONGITUDINAL OCCLUSIONS OF THE SUPERFICIAL FEMORAL ARTERY – A CASE REPORT OF A PATIENT WITH INTERMITTENT CLAUDICATION J Kardiol 2004;11: 118-22 217. Sabeti S, Schillinger M, Mlekusch W, Olbert F, Minar E: LONGTERM FOLLOW-UP AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE DISTAL ABDOMINAL AORTA. A CASE REPORT VASA 2004;33:49-51 IF 0.49 218. Alawami M, Schillinger M, Maca Th, Pollanz S, Minar E: LOW LEVEL LASER THERAPY FOR TREATMENT OF PRIMARY AND SECONDARY RAYNAUD S PHENOMENON VASA 2004;33:25-29 IF 0.49 219. Willfort-Ehringer A, Ahmadi R, Gessl A, Gschwandtner M, Haumer A, Lang W, Minar E, Zehetmayer S, Ehringer H: NEOINTIMAL PROLIFERATION WITHIN CAROTID STENTS IS MORE PRONOUNCED IN DIABETIC PATIENTS WITH INITIAL POOR GLYCAEMIC STATE Diabetologia 2004 ;47:400-406 IF 5.69 220. Bellmann R, Kuchling G, Dehghanyar P, Zeitlinger M, Minar E, Mayer BX, Müller M, Joukhadar Ch: TISSUE PHARMAKOKINETICS OF LEVOFLOXACIN IN HUMAN SOFT TISSUE INFECTIONS Br J Clin Pharmacol 2004;57:563-68 IF 2.53 221. Schillinger M, Exner M, Mlekusch W, Amighi J, Sabeti S, Rumpold H, Wagner O, Minar E: STATIN THERAPY IMPROVES CARDIOVASCULAR OUTCOME OF PATIENTS WITH PERIPHERAL ARTERY DISEASE Eur Heart J 2004;25:742-48 IF 6.0 222. Exner M, Schillinger M, Minar E, Mlekusch W, Sabeti S, Endler G,Raith M, Mannhalter Ch, Wagner O: INTERLEUKIN-6 PROMOTER GENOTYPE AND RESTENOSIS AFTER FEMOROPOPLITEAL BALLOON ANGIOPLASTY: INITIAL OBSERVATIONS Radiology 2004; 231:839-844 IF 4.81 223. Schillinger M, Exner M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Wagner O, Minar E: EFFECT OF SMOKING ON RESTENOSIS DURING THE 1ST YEAR AFTER LOWER-LIMB ENDOVASCULAR INTERVENTIONS Radiology 2004; 231: 31-838 IF 4.81 Protective Effect of Smoking: Misleading Use of Statistics Letter to the Editor; Radiology 2004;233:934. 224. Schillinger M, Exner M, Sabeti S, Amighi J, Wagner O, Ahmadi R, Minar E: EXCESSIVE CAROTID INSTENT NEOINTIMA FORMATION PREDICTS LATE CARDIOVASCULAR EVENTS JEVT 2004;11:229-39 IF 2.63 225. Kyrle PA, Minar E, Bialonczyk Ch, Hirschl M, Weltermann A, Eichinger S: THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN MEN AND WOMEN NEJM 2004;350:2558-63 IF 34.83 226. Al-Awami M, Schillinger M, Minar E: VASOSPASM OF THE SCROTUM –A MANIFESTATION OF RAYNAUD S PHENOMENON VASA 2004;33:87-88 IF 0.49 227. Sabeti S, Schillinger M, Mlekusch W, Nachtmann T, Willfort A, Haumer M, Nachtmann T Müllner M, Lang W, Ahmadi R, Minar E: QUANTIFICATION OF INTERNAL CAROTID ARTERY STENOSIS WITH DUPLEX US: COMPARATIVE ANALYSIS OF DIFFERENT FLOW VELOCITY CRITERIA Radiology 2004;232: 431-439 IF 4.81 228. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, and Minar E: PRIMARY PATENCY OF FEMOROPOPLITEAL ARTERIES TREATED WITH NITINOL VERSUS STAINLESS STEEL SELF-EXPANDING STENTS: PROPENSITY SCORE-ADJUSTED ANALYSIS STENTS Radiology 2004;232: 516-521 IF 4.81 229. Mlekusch W, Exner M, Sabeti S, Amighi J, Schlager O, Wagner O, Minar E, Schillinger M: SERUM CREATININE PREDICTS MORTALITY IN PATIENTS WITH PERIPHERAL ARTERY DISEASE – INFLUENCE OF DIABETES AND HYPERTENSION. Atherosclerosis 2004;175:361-67 IF 3.60 230. Exner M, Minar E, Wagner O, Schillinger M: THE ROLE OF HEME OXYGENASE-1 PROMOTOR POLYMORPHISMS IN HUMAN DISEASE Free Rad Biol Med 2004; 37: 1097-1104 IF 5.06 231. Mlekusch W, Schillinger M, Sabeti S, Alawami M, Gschwandtner M, Minar E: EFFECTS OF INTRAVENOUS PROSTAGLANDIN E1 ON ARTERIAL COMPLIANCE: A RANDOMIZED CONTROLLED TRIAL VASA 2004;33:131-136 232. Gyöngyösi M, Strehblow Ch, Haumer M, Wexberg P, Sperker W, Lehr St, Glogar D, Pasterkamp G, Minar E: VASCULAR REMODELLING IN ATHEROSCLEROTIC FEMORAL ARTERIES: THREE-DIMENSIONAL US ANALYSIS Radiology 2004; 233:366-375 IF 4.81 233. Steiner S, Cejna M, Nasel Ch, Minar E, Kopp CW: SUCCESSFUL REVASCULARIZATION OF ACUTE CAROTID STENT THROMBOSIS BY FACILITATED THROMBOLYSIS Am J Neuroradiol 2004;25:1411-13 IF 2.63 234. Schillinger M, Exner M, Sabeti S, Mlekusch W, Amighi J, Handler S, Quehenberger P, Khalifeh N, Wagner O, Minar E: HIGH PLASMA HEPARIN COFACTOR II ACTIVITY PROTECTS FROM RESTENOSIS AFTER FEMOROPOPLITEAL STENTING Thromb Haemost 2004; 92:1108-13 IF 4.95 235. Minar E, Schillinger M: ENDOVASCULAR IRRADIATION AFTER FEMOROPOPLITEAL ANGIOPLASTY Radiology 2004; 233: 935-937( Letter to the Editor) 236. Amighi J, Schillinger M, Minar E: AKUTE BEINISCHÄMIE ALS KOMPLIKATION NACH EINER TRANSFEMORALEN PERKUTANEN ANGIOPLASTIE (KASUISTIK) J Gefässmed 2004;1: 12-14 237. Bucek RA, Vavrik J, Minar E, Lammer J, Tscholakoff D: MULTIMODALITY IMAGING OF HEMANGIECTASIA HYPERTROPHICANS (KLIPPEL-TRENAUNAY-PARKES-WEBER SYNDROME) Circulation.2004;110:e295 238. Graninger M, Reiter R, Drucker Ch, Minar E, Jilma B: ANGIOTENSIN RECEPTOR BLOCKADE DECREASES MARKERS OF VASCULAR INFLAMMATION J Cardiovasc Pharmacol 2004;44:335-339 IF 1.90 239. Ziegler S, Gschwandtner ME, Zöch C, Barth A, Minar E, Rüdiger HW, Osterode W: LASER DOPPLER ANEMOMETRY DISTINGUISHES PRIMARY RAYNAUD PHENOMENON FROM VWF SYNDROME Microvascular Research 2004; 68:203-208. IF: 1.86 240. Kirisits CH, Pokrajac B, Berger D, Minar E, Pötter R, Georg D: TREATMENT PARAMETERS FOR BETA AND GAMMA DEVICES IN PERIPHERAL ENDOVASCULAR BRACHYTHERAPY Int J Rad Onc Biol Phys 2004;60:1652-59 IF 4.28 241. Schillinger M, Minar E: ADVANCES IN VASCULAR BRACHYTHERAPY OVER THE LAST 10 YEARS: FOCUS ON FEMOROPOPLITEAL APPLICATIONS JEVT 2004; 11( SUPPL II): II -180 – II -191 IF 2.64 242. Langer O, Brunner M, Zeitlinger M, Ziegler S, Muller U, Dobrozemsky G, Lackner E, Joukhadar C, Mitterhauser M, Wadsak W, Minar E, Dudczak R, Kletter K, Muller M. IN VITRO AND IN VIVO EVALUATION OF [(18)F]CIPROFLOXACIN FOR THE IMAGING OF BACTERIAL INFECTIONS WITH PET. Eur J Nucl Med Mol Imaging. 2005;32:143-50 IF 3.93 243. Reiter M, Wirth S, Pourazim A, Baghestanian M, Minar E, Bucek R: STATIN THERAPY HAS NO SIGNIFICANT EFFECT ON SKIN TISSUE CHOLESTEROL: RESULTS FROM A PROSPECTIVE RANDOMIZED TRIAL Clin Chem 2005 ;51:252-254 IF 6.50 244. Pokrajac B, Pötter R, Wolfram R, Budinsky A, Kirisits Ch, Lileg B, Mendel H, Sabeti S, Schmid R, Minar E: ENDOVASCULAR BRACHYTHERAPY PREVENTS RESTENOSIS AFTER FEMOROPOPLITEAL ANGIOPLASTY: RESULTS OF THE VIENNA-3 RANDOMISED MULTICENTER STUDY Radiother Oncol 2005; 74:3-9 IF 3.03 245. Ziegler S, Mittermayer F, Plank C, Minar E, Wolzt M, Schernthaner GH: HOMOCYSTEINE-LOWERING THERAPY DOES NOT AFFECT PLASMA ADMA CONCENTRATIONS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE J Clin Endocr Metab 2005; 90:2175-78 IF 5.78 246. Maca Th, Schillinger M, Hamwi A, Mlekusch W, Sabeti S, Wagner O, Minar E: INSULIN, C-PEPTIDE, AND RESTENOSIS AFTER FEMORAL ARTERY BALLOON ANGIOPLASTY IN TYPE II DIABETIC AND NON-DIABETIC PATIENTS JVIR 2005;16:31-35 IF 2.21 247. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M: PRIMARY PATENCY OF LONG-SEGMENT SELF-EXPANDING NITINOL STENTS IN THE FEMOROPOPLITEAL ARTERIES JEVT 2005;12:6-12 IF 2.64 248. Vormittag R, Vukovich Th, Schönauer V, Lehr St, Minar E, Bialonczyk Ch, Hirschl M, Pabinger I: BASAL HIGH-SENSITIVITY-C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH SPONTANEOUS VENOUS THROMBOEMBOLISM Thromb Haemost 2005;93:488-93 IF 4.95 249. Ziegler S, Zöch C, Gschwandtner M, Eckhardt G, Windberger U, Minar E. Rüdiger H, Osterode W: THERMOREGULATION AND RHEOLOGICAL PROPERTIES OF BLOOD IN PRIMARY RAYNAUD S PHENOMENON AND THE VIBRATION-INDUCED WHITE-FINGER SYNDROME Int Arch Occup Environ Health 2005; 78:218-22 IF 1.39 250. Bartok A, Steiner S, Seidinger D, Jetzl A, Huber K, Minar E, Stefenelli Th, Kopp CW: ATORVASTATIN REDUCES THROMBIN GENERATION AFTER PERCUTANEOUS CORONARY INTERVENTION INDEPENDENT OF SOLUBLE TISSUE FACTOR Thromb Res 2005; 115:469-474 IF 1.71 251. Steiner S, Speidl W, Pleiner J, Seidinger D, Zorn G, Kaun CH, Wojta J, Huber K, Minar E, Wolzt M, Kopp CW: SIMVASTATIN BLUNTS ENDOTOXIN-INDUCED TISSUE FACTOR IN VIVO Circulation 2005;111:1841-46 IF 12.56 252. Amighi J, Sabeti S, Dick P, Schlager O, Ahmadi R, Minar E, Schillinger M: IMPACT OF THE RAPID-EXCHANGE VERSUS OVER-THE-WIRE TECHNIQUE ON PROCEDURAL COMPLICATIONS OF RENAL ARTERY ANGIOPLASTY JEVT 2005;12:233-39 IF 1.85 253. Sherif C, Dick P, Sabeti S, Mlekusch W, Amighi J, Ahmadi R, Lalouschek W, Minar E, Schillinger M: NEUROLOGICAL OUTCOME OF CONSERVATIVE VERSUS ENDOVASCULAR TREATMENT OF PATIENTS WITH ASYMPTOMATIC HIGH-GRADE CAROTID ARTERY STENOSIS: A PROPENSITY SCORE ADJUSTED ANALYSIS JEVT 2005; 12:145-155 IF 1.85 254. Schillinger M,Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, Timmel E, Kickinger B, Minar C, Pones M, Lalouschek W, Rumpold H, Maurer G, Wagner O, Minar E:N Minar E: INFLAMMATION AND CAROTID ARTERY- RISK FOR ATHEROSCLEROSIS STUDY (ICARAS) Circulation 2005;111: 2203-09 IF 12.56 255. Haumer M, Amighi J, Exner M, Mlekusch W, Sabeti S , Schlager O, Schwarzinger I, Wagner O, Minar E, Schillinger M: ASSOCIATION OF NEUTROPHILS AND FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE J Vasc Surg 2005;41. 610-17 IF 2.73 256. Pokrajac B, Ahmadi R, Schmid R, Schillinger M, Kirisits Ch, Minar E, Pötter R: 3D- CONFORMAL RADIOTHERAPY FOR PREVENTION OF CAROTID RECURRENT IN-STENT RESTENOSIS.INITIAL EXPERIENCE Wien Klin Wochenschr 2005;117: 293-96 IF 0.77 257. Mlekusch W, Schillinger M, Minar E: TWENTY-EIGHT YEAR OLD HIV POSITIVE MALE PATIENT WITH
ERGOTISM. INTERACTION OF ERGOT-ALKALOIDS AND PROTEASE-
INHIBITORS.
Eur J Vasc Endovasc Surg. 2005;29: 556 IF 1.68

258. Dick P, Sherif C, Sabeti S, Amighi J, Minar E, Schillinger M: GENDER DIFFERENCES IN OUTCOME OF CONSERVATIVELY TREATED PATIENTS WITH ASYMPTOMATIC HIGH GRADE CAROTID STENOSIS Stroke 2005; 36:1178-83 IF 5.75 259. Speidl W, Exner M, Amighi J, Kastl St, Zorn G, Maurer G, Wagner O, Huber K, Minar E, Wojta J, Schillinger M: COMPLEMENT COMPONENT C5A PREDICTS FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WITH ADVANCED ATHEROSCLEROSIS Eur Heart J 2005; 26:2294-99 IF 6.24 260. Ziegler S, Schillinger M, Funk M, Felber K, Exner M, Mlekusch W, Sabeti S, Amighi J, Minar E, Brunner M, Müller M, Mannhalter Ch: ASSOCIATION OF A FUNCTIONAL POLYMORPHISM IN THE CLOPIDOGREL TARGET RECEPTOR GENE, P2Y12 AND THE RISK FOR ISCHEMIC CEREBROVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE Stroke 2005; 36: 1394-99 IF 5.75 261. Sabeti S, Exner M, Mlekusch W, Amighi J, Quehenberger P, Rumpold H, Maurer G, Minar E, Wagner O, Schillinger M: PROGNOSTIC IMPACT OF FIBRINOGEN IN CAROTID ATHEROSCLEROSIS: NON-SPECIFIC INDICATOR OF INFLAMMATION OR INDEPENDENT PREDICTOR OF DISEASE PROGRESSION? Stroke 2005 ; 36:1400-04 IF 5.75 262. Dick P, Rand T, Schillinger M, Minar E: BEHANDLUNG EINES PSEUDOANEURYSMAS DER ARTERIA FEMORALIS COMMUNIS MITTELS STENTGRAFT- IMPLANTATION Z Gefäßmed 2005; 2:19-21 263. Wolfram R, Budinsky A, Pokrajac B, Pötter R, Minar E: VASCULAR BRACHYTHERAPY WITH 192-IRIDIUM AFTER FEMOROPOPLITEAL STENT IMPLANTATION IN HIGH RISK PATIENTS : TWELVE-MONTH FOLLOW-UP RESULTS FROM THE VIENNA-5 TRIAL Radiology 2005; 236:343-51 IF 5.07 264. Wolfram R, Budinsky A, Pokrajac B, Pötter R, Minar E: ENDOVASCULAR BRACHYTHERAPY: RESTENOSIS IN DE NOVO VERSUS RECURRENT LESIONS OF FEMOROPOPLITEAL ARTERY – THE VIENNA EXPERIENCE Radiology 2005; 236:338-42 IF 5.07 265. Steiner S, Niessner A, Ziegler S, Richter B, Seidinger D, Pleiner J, Penka M, Wolzt M, Huber K, Wojta J, Minar E, Kopp CW: ENDURANCE TRAINING INCREASES THE NUMBER OF ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH CARDIOVASCULAR RISK AND CORONARY ARTERY DISEASE Atherosclerosis 2005; 181:305-10 IF 3.60 266. Ziegler S, Kudlacek St, Luger A, Minar E: OSTEOPROTEGERIN PLASMA CONCENTRATIONS CORRELATE WITH SEVERITY OF PERIPHERAL ARTERIAL DISEASE Atherosclerosis 2005; 182: 175-80 IF 3.60 267. Boltuch J, Sabeti S, Amighi J, Dick P, Mlekusch W, Schlager O, Ahmadi R, Minar E, Schillinger M: PROCEDURE-RELATED COMPLICATIONS AND EARLY NEUROLOGICAL ADVERSE EVENTS OF UNPROTECTED AND PROTECTED CAROTID STENTING –TEMPORAL TRENDS IN A CONSECUTIVE PATIENT SERIES JEVT 2005; 12: 538-47 268. Haider D, Bucek RA, Giurgea A, Maurer G, Glogar H, Minar E, Wolzt M, Mehrabi M, Baghestanian M: THE PROSTAGLANDIN E-1 ANALOG ALPROSTADIL INDUCES VEGF AND ENOS EXPRESSION IN ENDOTHELIAL CELLS Am J Physiol Heart Circ Physiol. 2005; 289: H2066-72 IF 3.54 269. Steiner S, Schaller G, Puttinger H, Födinger M, Kopp CW, Seidinger D, Grisar J, Hörl W, Minar E, Vychytil A, Wolzt M, Sunder-Plassmann G: HISTORY OF CARDIOVASCULAR DISEASE IS ASSOCIATED WITH ENDOTHELIAL PROGENITOR CELLS IN PERITONEAL DIALYSIS PATIENTS Am J Kidney Dis 2005; 46:520-28 IF 4.0 270. Hoke M, Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Schneider B, Kollars M, Weltermann A, Eichinger S: TISSUE FACTOR PATHWAY INHIBITOR AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM Thromb Haemost 2005;94: 787-790 IF 3.41 271. Ziegler S, Alt E, Brunner M, Speiser W, Minar INFLUENCE OF SYSTEMIC INFLAMMATION ON THE INTERPRETATION OF RESPONSE TO ANTIPLATELET THERAPY, MONITORED BY PFA-100 Semin Thromb Hemost. 2005 ; 31:416-9 IF 2.0 272. Lehrner J, Willfort A, Mlekusch I, Guttmann G, Minar E, Ahmadi R, Lalouschek W, Deecke L, Lang W: NEUROPSYCHOLOGICAL OUTCOME 6 MONTHS AFTER UNILATERAL CAROTID STENTING J Clin Exp Neuropsychol. 2005 ;27(7):859-66 IF 1.37 273. Marculescu R, Sodeck G, Domanovits H, Hobusch G, Exner M, Heinzl H, Huber K, Mannhalter Ch, Minar E, Wagner O, Schillinger M: INTERLEUKIN-1 GENE CLUSTER VARIANTS AND ABDOMINAL AORTIC ANEURYSMS. A MATCHED CASE CONTROL STUDY Thromb Haemost 2005; 94:646-50 IF 3.06 274. Vormittag R, Vukovich Th, Mannhalter C, Minar E, Schönauer V, Bialonczyk Ch, Hirschl M, Pabinger I: HAPTOGLOBIN PHENOTYPE 2-2 AS A POTENTIALLY NEW RISK FACTOR FOR SPONTANEOUS VENOUS THROMBOEMBOLISM Haematologica 2005;90: 1557-61 IF 4.19 275. Schillinger M, Minar E: CRUSH-STENTING DER UNTERSCHENKELGEFÄßE Z GEFÄßMED 2005; 3:16-17 276. Dick P, Schillinger M, Minar E, Mlekusch W, Amighi J, Sabeti S, Schlager O, Raith M, Endler G, Mannhalter Ch, Wagner O, Exner M: HEME OXYGENASE-1 GENOTYPE AND CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WIT PERIPHERAL ARTERY DISEASE Eur J Clin Invest 2005; 35:731-37 IF 2.68 277. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E, Schillinger M: LONG-SEGMENT SFA STENTING—THE DARK SIDES: IN-STENT RESTENOSIS, CLINICAL DETERIORATION, AND STENT FRACTURES JEVT 2005; 12: 676-84 IF 1.80 278. Mlekusch W, Haumer M, Mlekusch I, Schillinger M, Minar E: PERCUTANEOUS THROMBIN INJECTION IN IATROGENIC
PSEUDOANEURYSM OF THE COMMON FEMORAL ARTERY
Z GEFÄßMED 2005; 2:18-19

279. Stain M, Schönauer V, Minar E, Bialonczyk Ch, Hirschl M, Weltermann A, Kyrle PA, Eichinger S: THE POSTTHROMBOTIC SYNDROME: RISK FACTORS AND IMPACT ON THE COURSE OF THROMBOTIC DISEASE J Thromb Haemost 2005; 3: 2671-76 IF 5.26 280. Giurgea G, Margeta C, Maca T, Rezaie-Majd A, Bucek R, Manavi M, Afarideh R, Minar E, Baghestanian M: SIMVASTATIN REDUCES SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN HYPERCHOLESTEROLEMIC PATIENTS 2006 ;47(1):30-36. IF 1.31 281. Vormittag R, Funk M, Mannhalter C, Schönauer V, Vukovich T, Minar E, Bialonczyk C, Hirschl M, Pabinger I C-REACTIVE PROTEIN 3 UTR(+1444)C>T POLYMORPHISM IN PATIENTS WITH SPONTANEOUS VENOUS THROMBOEMBOLISM Atherosclerosis 2006; 188:406-411 IF 3.77 282. Rand T, Basile A, Cejna M, Funovics M, Gschwendtner M, Haumer M, von Katzler I, Kettenbach J, Lomoschitz F, Luft C, Minar E, Schneider B, Schoder M, Lammer J: PTA VERSUS CARBOFILM COATED STENTS IN INFRAPOPLITEAL ARTERES: PILOT STUDY Cardiovasc Intervent Radiol 2006; 29:29-38 IF 0.91 283. Hron G, Eichinger S, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Stain M, Gartner V, Kyrle PA: FAMILY HISTORY FOR VENOUS THROMBOEMBOLISM AND THE RISK FOR RECURRENCE Am J Med 2006; 119:50-53 IF 4.39 284. Mlekusch W, Dick P, Haumer M, Sabeti S, Minar E, Schillinger M: ARTERIAL PUNCTURE SITE MANAGEMENT AFTER PERCUTANEOUS TRANSLUMINAL PROCEDURES USING A HEMOSTATIC WOUND DRESSING (CLO-SUR P.A.D.) VERSUS CONVENTIONAL MANUAL COMPRESSION: A RANDOMIZED CONTROLLED TRIAL JEVT 2006; 13:23-31 IF 1.80 285. Steiner S, Winkelmayer W, Kleinert J, Grisar J, Seidinger D, Kopp CW,
Watschinger B, Minar E, Hörl W, Födinger M, Sunder-Plassmann G: ENDOTHELIAL PROGENITOR CELLS IN KIDNEY TRANSPLANT RECIPIENTS Transplantation 2006;81:599-606 IF 3.88 286. Schernthaner GH, Plank C, Minar E, Bieglmayer C, Koppensteiner R,
Schernthaner G: NO EFFECT OF HOMOCYSTEINE-LOWERING THERAPY ON VASCULAR INFLAMMATION AND HAEMOSTASIS IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Eur J Clin Invest 2006; 36: 333-339 IF 2.68 287. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E: BALLOON ANGIOPLASTY VS. IMPLANTATION OF NITINOL STENTS IN THE SUPERFICIAL FEMORAL ARTERY NEJM 2006; 354: 1879-88 IF 44.01 288. Vormittag R, Hsieh K, Kaider A, Minar E, Bialonczyk Ch, Hirschl M, Mannhalter C, Pabinger I: INTERLEUKIN-6 AND INTERLEUKIN-6 PROMOTOR POLYMORPHISM (-174) G>C IN PATIENTS WITH SPONTANEOUS VENOUS THROMBOEMBOLISM Thromb Haemost 2006; 95: 802-806 IF 3.06 289. Dick P, Mlekusch W, Sabeti S, Amighi J, Schlager O, Haumer M, Minar E, Schillinger M: OUTCOME AFTER ENDOVASCULAR TREATMENT OF DEEP FEMORAL ARTERY STENOSIS – RESULTS IN A CONSECUTIVE PATIENT SERIES AND SYSTEMATIC REVIEW OF THE LITERATURE JEVT 2006; 13:221-28 IF 1.80 290. Bucek RA, Puchner S, Haumer M, Rand T, Sabeti S, Minar E, Lammer J: GRADING OF INTERNAL CAROTID ARTERY STENOSIS: COMPARATIVE ANALYSIS OF DIFFERENT FLOW VELOCITY CRITERIA AND MULTI-DETECTOR COMPUTED TOMOGRAPHIC ANGIOGRAPHY JEVT 2006: 13: 182-89 IF 1.80 MYELOPEROXIDASE PREDICTS PROGRESSION OF CAROTID STENOSIS IN STATES OF LOW HIGH-DENSITY LIPOPROTEIN CHOLESTEROL 2006; 47:2212-8 IF 9.20 292. Bucek RA, Reiter M, Wirth S, Pourazim A, Minar E:
INFLUENCE OF HMG-COA-REDUCTASE INHIBITORS ON THE BODY FAT STATUS VASA 2006; 35: 92-95 IF 0.51 293. Mlekusch W, Mlekusch I, Minar E, Haumer M, Kopp CW, Ahmadi R, Lehrner J, Schillinger M: IS THERE IMPROVEMENT OF "VASCULAR DEPRESSION" AFTER CAROTID ARTERY STENT PLACEMENT? Radiology 2006 ;240:508-14 IF 5.25 294. Schillinger M, Dick P, Wiest G, Gentzsch S, Sabeti S, Haumer M, Willfort A, Nasel C, Wöber C, Zeitlhofer J, Minar E: COVERED VERSUS BARE SELF-EXPANDING STENTS FOR ENDOVASCULAR TREATMENT OF CAROTID ARTERY STENOSIS: A STOPPED RANDOMIZED TRIAL J Endovasc Ther. 2006; 13:312-9 IF 1.80 295. Mlekusch W, Haumer M, Mlekusch I, Dick P, Steiner-Boeker S, Bartok A, Sabeti S, Exner M, Wagner R, Minar E, Schillinger M. PREDICTION OF IATROGENIC PSEUDOANEURYSM AFTER PERCUTANEOUS ENDOVASCULAR PROCEDURES. Radiology 2006; 240: 597-602 IF 5.25 296. Reiter M, Bucek R, Effenberger I, Boltuch J, Lang W, Ahmadi R, Minar E and Schillinger M: PLAQUE ECHOLUCENCY IS NOT ASSOCIATED WITH THE RISK OF STROKE IN CAROTID STENTING Stroke 2006; 37: 2378-80 IF 5.85 297. Schillinger T, Kluger W, Exner M, Mlekusch W, Sabeti S, Amighi J, Wagner O,
Minar E and Schillinger M: DENTAL AND PERIODONTAL STATUS AND RISK FOR PROGRESSION OF CAROTID ATHEROSCLEROSIS. THE INFLAMMATION AND CAROTID ARTERY RISK FOR ATHEROSCLEROSIS STUDY DENTAL SUBSTUDY. Stroke 2006; 37:2271-2276 IF 5.85 THE CARDIOVASCULAR RISK MARKER ASYMMETRICAL DIMETHYLARGININE IS NOT AFFECTED BY VENOUS THROMBOEMBOLISM. Transl Res 2006; 148:26-29 299. Mittermayer F, Krzyzanowska K, Exner M, Mlekusch W, Amighi J, Sabeti S, Minar E, Müller M, Wolzt M, Schillinger M: ASYMMETRIC DIMETHYLARGININE PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ADVANCED PERIPHERAL ARTERY DISEASE Arterioscler Thromb Vasc Biol 2006; 26:2536-40 IF 7.05 300. Bucek RA, Puchner S, Haumer M, Rand T, Minar E, Lammer J: GRADING OF INTERNAL CAROTID ARTERY STENOSIS: CAN CTA OVERCOME THE CONFUSION? JEVT 2006;13:443-50 IF 2.13 301. Wolfram R, Budinsky A, Pokrajac B, Pötter R, Minar E: ENDOVASCULAR BRACHYTHERAPY FOR PROPHYLAXIS OF RESTENOSIS AFTER FEMOROPOPLITEAL ANGIOPLASTY: FIVE-YEAR FOLLOW-UP--PROSPECTIVE RANDOMIZED STUDY Radiology 2006; 240: 878-884 IF 5.25 302. Reiter M, Wirth S, Pourazim A, Exner M, Baghestanian M, Rumpold H, Minar E, Bucek RA: SKIN CHOLESTEROL: TEST PERFORMANCE, EVALUATION OF POTENTIAL DETERMINANTS AND CORRELATION ANALYSIS WITH CARDIOVASCULAR RISK FACTORS AND CIRCULATING MARKERS OF INFLAMMATION Vasa 2006; 35: 167-73 IF 0.57 303. Mlekusch W, Haumer M, Koppensteiner R, Minar E FALLBERICHT: HAUTNEKROSE NACH KANÜLIERUNG DER A. RADIALIS ZUM INVASIVEN MONITORING Zeitschrift fur Gefassmedizin 2006; 3(4) : 26-27 Reiter M, Horvath R, Rinner W, Puchner S, Polterauer P, Lammer J, Minar E, Bucek R: PLAQUE IMAGING OF THE INTERNAL CAROTID ARTERY – CORRELATION OF B-FLOW IMAGING WITH HISTOPATHOLOGY Am J Neuroradiol. 2007 ; 28(1):122-6. IF 2.28 305. Speidl W, Exner M, Amighi J, Mlekusch W, Sabeti S, Kastl s, Zorn G, Maurer G, Wagner O, Huber K, Minar E, Wojta J, Schillinger M: COMPLEMENT COMPONENT C5A PREDICTS RESTENOSIS AFTER SUPERFICIAL FEMORAL ARTERY BALLOON ANGIOPLASTY. JEVT 2007; 14: 62-69 IF 2.13 306. Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, Diehm C,
Biamino G, Vermassen F, Scheinert D, van Sambeek M, Schillinger M: A CALL FOR UNIFORM REPORTING STANDARDS IN STUDIES ASSESSING ENDOVASCULAR TREATMENT FOR CHRONIC ISCHAEMIA OF LOWER LIMB ARTERIES Eur Heart J 2007; 28:798-805 IF 7.28 307. Schillinger m, Minar E: ENDOVASCULAR STENT IMPLANTATION FOR TREATMENT OF PERIPHERAL ARTERY DISEASE Eur J Clin Invest 2007; 37: 165-170 IF 2.85 308. Maca T, Mlekusch W, Doweik L, Budinsky AC, Bischof M, Minar E, Schillinger
M: INFLUENCE AND INTERACTION OF DIABETES AND LIPOPROTEIN (A) SERUM LEVELS ON MORTALITY OF PATIENTS WITH PERIPHERAL ARTERY DISEASE Eur J Clin Invest 2007; 37: 180 – 186 IF 2.85 309. Schlager O, Exner M, Mlekusch W, Sabeti S, Amighi J, Dick P, Wagner O,
Koppensteiner R, Minar E, Schillinger M: C-REACTIVE PROTEIN PREDICTS FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WITH CAROTID STENOSIS. Stroke 2007; 38: 1263-68 IF 5.39 310. Puchner S, Haumer M, Rand T, Reiter M, Minar E, Lammer J, Bucek R:
CTA IN THE DETECTION AND QUANTIFICATION OF VERTEBRAL ARTERY PATHOLOGIES: A CORRELATION WITH COLOR DOPPLER SONOGRAPHY Neuroradiology. 2007; 49:645-50 IF 1.62 311. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E SUSTAINED BENEFIT AT 2 YEARS OF PRIMARY FEMOROPOPLITEAL STENTING COMPARED WITH BALLOON ANGIOPLASTY WITH OPTIONAL STENTING Circulation 2007; 115: 2745-49 IF 10.94 312. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T.
NITINOL STENT IMPLANTATION VERSUS PERCUTANEOUS
TRANSLUMINAL ANGIOPLASTY IN SUPERFICIAL FEMORAL ARTERY
LESIONS UP TO 10 CM IN LENGTH. THE FEMORAL ARTERY STENTING
TRIAL (FAST)
Circulation 2007; 116:285-92 IF 10.94

313. Vormittag R, Vukovich Th, Stain M, Lehr S, Minar E, Pabinger I: LIPOPROTEIN(A) IN PATIENTS WITH SPONTANEOUS VENOUS THROMBOEMBOLISM Thromb Res 2007; 120:15-20 IF 2.06 314. Reiter M, Wirth S, Pourazim A, Puchner S, Baghestanian M, Minar E, Bucek RA. SKIN TISSUE CHOLESTEROL IS NOT RELATED TO VASCULAR OCCLUSIVE DISEASE Vasc Med 2007; 12: 129-134 IF 0.98 315. Bucek RA, Puchner St, Haumer M, Reiter M, Minar E, Lammer J. CTA QUANTIFICATION OF INTERNAL CAROTID ARTERY STENOSIS: APPLICATION OF LUMINAL AREA VS. LUMINAL DIAMETER MEASUREMENTS AND ASSESSMENT OF INTER-OBSERVER VARIABILITY J Neuroimaging 2007; 17:219-226 IF 1.30 316. Puchner St, Stadler A, Minar E, Lammer J, Bucek RA: MULTIDETECTOR CT ANGIOGRAPHY IN THE FOLLOW-UP OF PATIENTS TREATED WITH RENAL ARTERY STENTS: VALUE OF DIFFERENT REFORMATION TECHNIQUES COMPARED WITH AXIAL SOURCE IMAGES JEVT 2007; 14: 387-94 IF 2.13 317. Sabeti S, Czerwenka-Wenkstetten A, Dick P, Schlager O, Amighi J, Mlekusch I, Mlekusch W, Loewe C, Cejna M, Lammer J, Minar E, Schillinger M. QUALITY OF LIFE AFTER BALLOON ANGIOPLASTY VERSUS STENT IMPLANTATION IN THE SUPERFICIAL FEMORAL ARTERY: FINDINGS FROM A RANDOMIZED CONTROLLED TRIAL JEVT 2007; 14:431-437 IF 2.13 318. Schlager O, Francesconi M, Haumer M, Dick P, Sabeti S, Amighi J, Mlekusch W, Koppensteiner R, Minar E, Schillinger M. DUPLEX SONOGRAPHY VERSUS ANGIOGRAPHY FOR ASSESSMENT OF FEMOROPOPLITEAL ARTERIAL DISEASE IN A "REAL-WORLD" SETTING. JEVT 2007; 14:452-9 IF 2.13 319. Sabeti S, Schlager O, Exner M, Mlekusch W, Amighi J, Dick P, Maurer G, Huber K, Koppensteiner R, Wagner O, Minar E, Schillinger M. PROGRESSION OF CAROTID STENOSIS DETECTED BY DUPLEX ULTRASONOGRAPHY PREDICTS ADVERSE OUTCOMES IN CARDIOVASCULAR HIGH-RISK PATIENTS Stroke. 2007; 38: 2887-94 IF 5.39 320. Schillinger M, Diehm N, Baumgartner I, Minar E: TASC II SECTION F ON REVASCULARIZATION: COMMENTARY FROM AN INTERVENTIONIST'S POINT OF VIEW JEVT 2007; 14: 734-42 IF 2.13 321. Zeller T, Saratzis N, Scheinert D, Minar E, Beregi J P, Schillinger M, Hausegger H. A, Amor M, Quaretti P, Moratto R, Dorange C, Boone E, Krankenberg H. NON-RANDOMIZED, PROSPECTIVE, MULTI-CENTRE EVALUATION OF THE ABSOLUTE .035 PERIPHERAL SELF-EXPANDING STENT SYSTEM FOR OCCLUDED OR STENOTIC SUPERFICIAL FEMORAL OR PROXIMAL POPLITEAL ARTERIES (ASSESS TRIAL): ACUTE AND 30-DAY RESULTS J Cardiovasc Surg 2007;48(6):719-26 IF 1.02 322. Eichinger S, Hron G, Hirschl M, Bialonczyk C, Minar E, Kollars M, Kyrle PA: PREDICTION OF RECURRENT VENOUS THROMBOEMBOLISM BY MEASURING PROC GLOBAL Thromb Haemost 2007; 98: 1232-1236 IF 2.80 323. Mlekusch W, Mlekusch I, Haumer M, Kopp CW, Lehrner J, Ahmadi R, Koppensteiner R, Minar E, Schillinger M:
IMPROVEMENT OF NEUROCOGNITIVE FUNCTION AFTER PROTECTED
CAROTID ARTERY STENTING
Catheter Cardiovasc Intervent 2008; 71:114-19 IF 1.75
324. Schillinger M, Gschwendtner M, Reimers B, Trenkler J, Stockx L, Mair J, Macdonald S, Karnel F, Huber K, Minar E: DOES CAROTID STENT CELL DESIGN MATTER? Stroke 2008;39:905-909 IF 6.30 325. Diehm N, Schillinger M, Minar E, Gretener S, Baumgartner I. TASC II SECTION E3 ON THE TREATMENT OF ACUTE LIMB ISCHEMIA: COMMENTARY FROM EUROPEAN INTERVENTIONISTS JEVT 2008; 15: 126-28 IF 2.39 326. Amighi J, Schillinger M, Dick P, Schlager O, Sabeti S, Mlekusch W, Haumer M, Mathies R, Heinzle G, Schuster A, Loewe C, Koppensteiner R, Lammer J, Minar E DE NOVO SUPERFICIAL FEMOROPOPLITEAL ARTERY LESIONS: PERIPHERAL CUTTING BALLOON ANGIOPLASTY AND RESTENOSIS RATES--RANDOMIZED CONTROLLED TRIAL. Radiology 2008; 247: 267-272 IF 5.56 327. Puchner S, Reiter M, Baros C, Minar E, Lammer J, Bucek RA. ASSESSMENT OF INTIMA-MEDIA THICKNESS OF CAROTID ARTERIES: EVALUATION OF AN AUTOMATED COMPUTER SOFTWARE Neuroradiology 2008; 50: 849-53 IF 1.76 328. Schillinger M, Minar E: LOCAL PACLITAXEL DELIVERY IN PERIPHERAL VASCULAR DISEASE NEJM 2008; 358: 2406 (Letter) 329. Dick P, Sabetis S, Mlekusch W, Schlager O, Amighi J, Haumer M, Cejna M, Minar E, Schillinger M. CONVENTIONAL BALLOON ANGIOPLASTY VERSUS PERIPHERAL CUTTING BALLOON ANGIOPLASTY FOR TREATMENT OF FEMOROPOPLITEAL ARTERY IN-STENT RESTENOSIS: INITIAL EXPERIENCERadiology. 2008; 248:297-302 IF 5.56 330. Schillinger M, Minar E: REGARDING "STENTING FOR FEMOROPOPLITEAL LESIONS" J Vasc Surg 2008;48:208 (Letter) 331. Eichinger S, Hron G, Bialonczyk C, Hirschl M, Minar E, Wagner O, Heinze G, Kyrle PA. OVERWEIGHT, OBESITY, AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM. Arch Intern Med 2008; 168: 1678-83 IF 8.39 332. The Botticelli Investigators. EFFICACY AND SAFETY OF THE ORAL DIRECT FACTOR XA INHIBITOR APIXABAN FOR SYMPTOMATIC DEEP VEIN THROMBOSIS. THE BOTTICELLI DVT DOSE-RANGING STUDY Journal of Thrombosis and Haemostasis 2008; 6: 1313–1318 IF 5.94 333. Reiter M, Effenberger I, Sabeti S, Mlekusch W, Schlager O, Dick P, Puchner S, Amighi J, Bucek RA, Minar E, Schillinger M. INCREASING CAROTID PLAQUE ECHOLUCENCY IS PREDICTIVE OF CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS Radiology 2008; 248: 1050-1055 IF 5.56 334. Dick P, Barth B, Mlekusch W, Sabeti S, Amighi J, Schlager O, Koppensteiner R, Minar E, Schillinger M. COMPLICATIONS AFTER PERIPHERAL VASCULAR INTERVENTIONS IN OCTOGENARIANS J ENDOVASC THER 2008;15:383–389 IF 2.39 335. Haumer, M., Gschwandtner, M.E., Minar, E HUNG TOGETHER, CAPTURED TOGETHER: TWO UNUSUAL CASES OF EMBOLISM PROTECTION BY MEANS OF A GUIDE WIRE Zeitschrift fur Gefassmedizin 2008; 5: 23-25 336. Mlekusch W, Minar E, Dick P, Sabeti S, Bartok A, Haumer M, Bonelli M, Vormittag L, Koppensteiner R, Schillinger M: ACCESS SITE MANAGEMENT AFTER PERIPHERAL PERCUTANEOUS TRANSLUMINAL PROCEDURES: NEPTUNE PAD COMPARED WITH CONVENTIONAL MANUAL COMPRESSION Radiology 2008; 249: 1058-63 IF 5.56 337. Schillinger M, Minar E: MATCHING CAROTID ANATOMY WITH CAROTID STENTS J Cardiovasc Surg 2008 ; 49: 723-7 IF 1.57 338. Eischer L, Gartner V, Schulman S, Kyrle PA, Eichinger S for the AUREC-FVIII investigators . 6 VERSUS 30 MONTHS ANTICOAGULATION FOR RECURRENT VENOUS THROMBOSIS IN PATIENTS WITH HIGH FACTOR VIII Ann Hematol 2009; 88(5) 485-90 IF 2.34 339. Steiner S, Sadushi R, Bartok A, Hammer A, Quehenberger P, Mannhalter C, Koppensteiner R, Minar E, Kopp CW. ASSOCIATION OF PERIPROCEDURAL NEUROLOGICAL DEFICIT IN CAROTID STENTING WITH INCREASED ANTICARDIOLIPIN ANTIBODIES Thromb Res. 2009;123(6):827-31 IF 2.04 340. Schlager O, Amighi J, Haumer M, Sabeti S, Dick P, Mlekusch W, Loewe C, Koppensteiner R, Minar E, Schillinger M: INFLAMMATION AND ADVERSE CARDIOVASCULAR OUTCOME IN PATIENTS WITH RENAL ARTERY STENOSIS AND PERIPHERAL ARTERY DISEASE Atherosclerosis 2009; 205:314-18 IF 4.60 341. Schillinger M, Minar E: PAST, PRESENT AND FUTURE OF FEMOROPOPLITEAL STENTING JEVT 2009; 16 (SUPPL 1): I147 – I152 IF 2.68 342. Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Düber C, Zeller T, Gussmann A, Lohle PN, Minar E, Scheinert D, Hausegger K, Schulte KL, Verbist J, Deloose K, Lammer J: .AMS INSIGHT-ABSORBABLE METAL STENT IMPLANTATION FOR TREATMENT OF BELOW-THE-KNEE CRITICAL LIMB ISCHEMIA: 6-MONTH ANALYSIS. Cardiovasc Intervent Radiol 2009; 32:424-36 IF 1.72 343. Kakkos SK, Sabetai M, Tegos T, Stevens J, Thomas D, Griffin M, Geroulakos G, Nicolaides AN; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. SILENT EMBOLIC INFARCTS ON COMPUTED TOMOGRAPHY BRAIN SCANS AND RISK OF IPSILATERAL HEMISPHERIC EVENTS IN PATIENTS WITH ASYMPTOMATIC INTERNAL CAROTID ARTERY STENOSIS 2009; 49:902-9 IF 3.77 344. Amighi J, Schlager O, Haumer M, Dick P, Mlekusch W, Loewe C, Böhmig G, Koppensteiner R, Minar E, Schillinger M. RENAL ARTERY STENOSIS PREDICTS ADVERSE CARDIOVASCULAR AND RENAL OUTCOME IN PATIENTS WITH PERIPHERAL ARTERY DISEASE Eur J Clin Invest. 2009; 39:784-92 IF 2.78 345. Pokrajac B, Kirisits C, Schmid R, Schillinger M, Berger D, Peer K, Tripuraneni P, Pötter R, Minar E. BETA ENDOVASCULAR BRACHYTHERAPY USING CO2- FILLED CENTERING CATHETER FOR TREATMENT OF RECURRENT SUPERFICIAL FEMOROPOPLITEAL ARTERY DISEASE. Cardiovasc Revasc Med. 2009; 10(3):162-5 346. Minar E, Schillinger M. NEW STENTS FOR SFA. J Cardiovasc Surg 2009 ; 50:635-45. IF 1.54 347. Zeller Th , Krankenberg H Steinkamp H, Rastan A, Sixt S, Schmidt A, Sievert H, Minar E, Bosiers M, Peeters P, Balzer J, Gray W, Tübler Th, Wissgott C, Schwarzwälder U, Scheinert. ONE-YEAR OUTCOME OF PERCUTANEOUS ROTATIONAL ATHERECTOMY WITH ASPIRATION IN INFRAINGUINAL PERIPHERAL ARTERIAL OCCLUSIVE DISEASE: THE MULTICENTER PATHWAY PVD TRIAL JEVT 2009; 16:653-62 IF 2.68 348. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Koppensteiner R, Minar E, Schillinger M. BALLOON ANGIOPLASTY VERSUS STENTING
WITH
NITINOL STENTS IN INTERMEDIATE LENGTH SUPERFICIAL FEMORAL
ARTERY LESIONS.
Catheter Cardiovasc Interv. 2009 74:1090-5 IF 2.25
349. Hoke M, Amighi J, Mlekusch W, Schlager O, Exner M, Sabeti S, Dick P, Koppensteiner R, Minar E, Rumpold H, Wagner O, Schillinger M Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis Stroke. 2010;41(4):674-9 350. Popovic M, Puchner S, Endler G, Foraschik C, Minar E, Bucek RA. THE EFFECTS OF ENDURANCE AND RECREATIONAL EXERCISE ON SUBCLINICAL EVIDENCE OF ATHEROSCLEROSIS IN YOUNG ADULTS Am J Med Sci 2010; 339:332-36 IF 1.51 351. Minar E. AAA – A FURTHER STEP TOWARDS A MORATORIUM FOR ASPIRIN IN THE PRIMARY PREVENTION VASA 2010; 39:119-122 (Editorial) 352. Berzaczy D, Berzaczy D, Popovic M, Reiter M, Puchner S, Weber M, Minar E, Bucek RA. QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC SUBCLAVIAN VEIN THROMBOSIS Thromb Res 2010;125:25-8. IF 2.45 353. Hoke M, Koppensteiner R, Schillinger M, Haumer M, Minar E, Wiesbauer F, Huber CD, Mlekusch W. D-DIMER TESTING IN THE DIAGNOSIS OF TRANSFEMORAL PSEUDOANEURYSM AFTER PERCUTANEOUS TRANSLUMINAL PROCEDURES J Vasc Surg 2010;52:383-7 354. Minar E, Schillinger M. CAROTID ARTERY STENTING: LAST CHANCE TO ESCAPE THE ALREADY PREPARED MORATORIUM? JEVT 2010; 17: 295-97 355. Minar E. RECENT ADVANCES IN PERIPHERAL IN-STENT RESTENOSIS
J Cardiovasc Surg 2010;51:539-41 356. Belch JJ, Dormandy J; CASPAR Writing Committee, Biasi BM, Cairols M,
Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. RESULTS OF THE RANDOMIZED, PLACEBO-CONTROLLED CLOPIDOGREL AND ACETYLSALICYLIC ACID IN BYPASS SURGERY FOR PERIPHERAL ARTERIAL DISEASE (CASPAR) TRIAL. J Vasc Surg. 2010;52(4):825-33357. 357. Hoke M, Schmidt B, Schillinger T, Kluger W, Wiesbauer F, Mlekusch W, Minar E, Schillinger M. EVIDENCE OF CAROTID ATHEROSCLEROSIS IN ORTHOPANTOMOGRAMS AND THE RISK FOR FUTURE CARDIOVASCULAR EVENTS. Vasa. 2010;39(4):298-304 358. Nicolaides AN for the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group (Collaborator Minar E). ASYMPTOMATIC INTERNAL CAROTID ARTERY STENOSIS AND CEREBROVASCULAR RISK STRATIFICATION. J Vasc Surg 2010;52:1486-96 359. Einstein Investigators (Collaborator Minar E). ORAL RIVAROXABAN FOR SYMPTOMATIC VENOUS THROMBOEMBOLISM N Engl J Med. 2010;363:2499-510. 360. Minar E. DRUG ELUTING STENTS ABOVE THE KNEE J Cardiovasc Surg 2011;52(2):225-9. IF 1.35 361. Amighi J, Hoke M, Mlekusch W, Schlager O, Exner M, Haumer M, Pernicka E, Koppensteiner R, Minar E, Rumpold H, Schillinger M, Wagner O. BETA 2 MICROGLOBULIN AND THE RISK FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH ASYMPTOMATIC CAROTID ATHEROSCLEROSIS Stroke. 2011 ;42:1826-33 IF 5.75 362. Kopp CW, Gremmel T, Steiner S, Seidinger D, Minar E, Maurer G, Huber K PLATELET-MONOCYTE CROSS TALK AND TISSUE FACTOR EXPRESSION IN STABLE ANGINA VS. UNSTABLE ANGINA/NON ST-ELEVATION MYOCARDIAL INFARCTION Platelets. 2011; 22(7):530-6 IF 2.11 363. Sixt S, Rastan A, Scheinert D, Krankenberg H, Steinkamp H, Schmidt A, Sievert H, Minar E, Bosiers M, Peeters P, Balzer JO, Tübler T, Wissgott C, Carpio Cancino OG, Schwarzwalder U, Zeller T. THE 1-YEAR CLINICAL IMPACT OF ROTATIONAL ASPIRATION ATHERECTOMY OF INFRAINGUINAL LESIONS. Angiology. 2011; 62(8):645-56 IF 1.0 364. Hoke M, Schillinger M, Dick P, Exner M, Koppensteiner R, Minar E, Mlekusch W, Schlager O, Wagner O, Mannhalter C. POLYMORPHISM OF THE PALLADIN GENE AND CARDIOVASCULAR OUTCOME IN PATIENTS WITH ATHEROSCLEROSIS. Eur J Clin Invest. 2011;41(4):365-71 IF 2.73 365. Sixt S, Scheinert D, Rastan A, Krankenberg H, Steinkamp H, Schmidt A, Sievert H, Minar E, Bosiers M, Peeters P, Balzer JO, Tübler T, Wissgott C, Nielsen C, Schwarzwälder U, Zeller T. ONE-YEAR OUTCOME AFTER PERCUTANEOUS ROTATIONAL AND ASPIRATION ATHERECTOMY IN INFRAINGUINAL ARTERIES IN PATIENT WITH AND WITHOUT TYPE 2 DIABETES MELLITUS. Ann Vasc Surg. 2011 ;25(4):520-9. IF 1.33 366. Langenberger H, Schillinger M, Plank C, Sabeti S, Dick P, Cejna M, Lammer J, Minar E, Loewe C. AGREEMENT OF DUPLEX ULTRASONOGRAPHY VS. COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR EVALUATION OF NATIVE AND IN- STENT SFA RE-STENOSIS-FINDINGS FROM A RANDOMIZED CONTROLLED TRIAL Eur J Radiol. 2011 Jun 22. [Epub ahead of print] IF 2.94 367. M. Schillinger, E.Minar. CLAUDICATION: TREATMENT OPTIONS FOR FEMOROPOPLITEAL DISEASE Progress in Cardiovascular Diseases 2011;54: 41–46 IF 4.85 368. Hoke M, Schillinger M, Zorn G, Wonnerth A, Amighi J, Mlekusch W, Speidl W,
Maurer G, Koppensteiner R, Minar E, Wojta J, Niessner A. THE PROGNOSTIC
IMPACT OF SOLUBLE APOPTOSIS-STIMULATING FRAGMENT ON
MORTALITY IN PATIENTS WITH CAROTID ATHEROSCLEROSIS
Stroke 2011;42:2465-70 IF 5.75
369. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi
A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J,
Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T
ESC GUIDELINES ON THE DIAGNOSIS AND TREATMENT OF PERIPHERAL
ARTERY DISEASES: DOCUMENT COVERING ATHEROSCLEROTIC DISEASE
OF EXTRACRANIAL CAROTID AND VERTEBRAL, MESENTERIC, RENAL,
UPPER AND LOWER EXTREMITY ARTERIES
Eur Heart J. 2011; 32:2851-906 IF 10.05
370. RE-NOVATE II Study Group ( Collaborator: E.Minar) ORAL DABIGATRAN
VERSUS ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER PRIMARY
TOTAL HIP ARTHROPLASTY (RE-NOVATE II). A RANDOMISED, DOUBLE-
BLIND, NON-INFERIORITY TRIAL.
Thromb Haemost 2011; 105:721-9 IF 4.70
371. Hoke M, Schillinger T, Mlekusch W, Wagner O, Minar E,
Schillinger M. THE IMPACT OF DENTAL DISEASE ON MORTALITY IN
PATIENTS WITH ASYMPTOMATIC CAROTID ATHEROSCLEROSIS.
Swiss Med Wkly. 2011; 141:w13236 IF 1.82
372. Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI;
ADOPT Trial Investigators. APIXABAN VERSUS ENOXAPARIN FOR
THROMBOPROPHYLAXIS IN MEDICALLY ILL PATIENTS.
N ENGL J MED. 2011; 365(23):2167-77
373. Hoke M, Pernicka E, Niessner A, Goliasch G, Amighi J, Koppensteiner R, Minar E,
Mlekusch W, Rumpold H, Wagner O, Schillinger M. RENAL FUNCTION AND
LONG-TERM MORTALITY IN PATIENTS WITH ASYMPTOMATIC CAROTID
ATHEROSCLEROSIS
Thromb Haemost. 2012;107: 150-57 IF 4.70
374 . Bergqvist D, Arcelus JI, Felicissimo P; ETHOS investigators. EVALUATION OF THE
DURATION OF THROMBOEMBOLIC PROPHYLAXIS AFTER HIGH-RISK
ORTHOPAEDIC SURGERY: THE ETHOS OBSERVATIONAL STUDY.
Thromb Haemost. 2012;;107(2):280-7. IF 4.70
375. Bergqvist D, Arcelus JI, Felicissimo P; ETHOS investigators. POST-DISCHARGE
COMPLIANCE TO VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HIGH-
RISK ORTHOPAEDIC SURGERY: RESULTS FROM THE ETHOS REGISTRY.
Thromb Haemost. 2012; 107(2):280-7. IF 4.70
376. Hoke M, Speidl W, Schillinger M, Minar E, Zehetmayer S, Schönherr M, Wagner O, Mannhalter C. POLYMORPHISM OF THE COMPLEMENT 5 GENE AND CARDIOVASCULAR OUTCOME IN PATIENTS WITH ATHEROSCLEROSIS Eur J Clin Invest. 2012 ;42(9):921-6 IF 3.02. 377. EINSTEIN–PE Investigators, Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. ORAL RIVAROXABAN FOR THE TREATMENT OF SYMPTOMATIC PULMONARY EMBOLISM. N Engl J Med. 2012; 366(14):1287-97 IF 53.3 378. Kalodiki E, Stvrtinova V, Allegra C, Andreozzi G, Antignani PL, Avram R, Brkljacic B, Cadariou F, Dzsinich C, Fareed J, Gaspar L, Geroulakos G, Jawien A, Kozak M, Lattimer CR, Minar E, Partsch H, Passariello F, Patel M, Pécsvárady Z, Poredos P, Roztocil K, Scuderi A, Sparovec M, Szostek M, Skorski M. SUPERFICIAL VEIN THROMBOSIS: A CONSENSUS STATEMENT Int Angiol. 2012;31(3):203-16. IF 1.65 379. Minar E. SHOULD I PREFER CHEST PAIN OVER LEG PAIN? Vasa 2012; 41 (2): 75-77 (Editorial) IF 1.31 380. Minar E, Schillinger M: INNOVATIVE TECHNOLOGIES FOR SFA OCCLUSIONS: DRUG COATED BALLOONS IN SFA LESIONS. J Cardiovasc Surg 2012;53(4):481-6 IF 1.56 . 381. Minar E. ENDOVASCULAR FIRST STRATEGY FOR ALL PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD) ? Interventional Cardiology 2012;4:393-395 (Editorial) 382. Goliasch G, Schillinger M, Mayer FJ, Wonnerth A, Koppensteiner R, Minar E, Maurer G, Niessner A, Hoke M. USEFULNESS OF HEMOGLOBIN LEVEL TO PREDICT LONG-TERM MORTALITY IN PATIENTS WITH ASYMPTOMATIC CAROTID NARROWING BY ULTRASONOGRAPHY Am J Cardiol. 2012 Aug 23. [Epub ahead of print IF 3.37 383. Minar E. RESUSCITATION OF ENDOVASCULAR BRACHYTHERAPY OWING TO IMPROVED LOGISTICS (COMMENTARY) Endovasc Ther 2012 ; 19(4):476-9 IF 2.86 384. Schillinger M, Minar E. PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERY DISEASE: NOVEL TECHNIQUES. Circulation. 2012;126(20):2433-40 IF 14.74 385. Hoke M, Ljubuncic E, Steinwender C, Huber K, Minar E, Koppensteiner R, Leisch F, Dick P, Kerschner K, Schillinger M, Hofmann R, Niessner A . A VALIDATED RISK SCORE TO PREDICT OUTCOMES AFTER CAROTID STENTING Circ Cardiovasc Interv. 2012;5: 386. E.Minar: FEMORAL STENTING: WHAT DO THE GUIDELINES TELL US J Cardiovasc Surg 2013; 387. Schulman et al for the RE-SONATE Trial Investigators. EXTENDED USE OF DABIGATRAN, WARFARIN, OR PLACEBO IN VENOUS THROMBOEMBOLISM N Engl J Med. 2013;368(8):709-18

Source: http://www.med.at/images/arztinfo/publikation/Publications--Minar.pdf